Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage
Kurian, A. W., Hartman, A. R., Mills, M. A., Ford, J. M., Daniel, B. L., & Plevritis, S. K. (2005). Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. HEALTH EXPECTATIONS, 8(3), 221–33.

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging
Plevritis, S. K., Kurian, A. W., Sigal, B. M., Daniel, B. L., Ikeda, D. M., Stockdale, F. E., & Garber, A. M. (2006). Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 295(20), 2374–84.

A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer
Kurian, A. W., Newton Thompson, R., Gaw, A. F., Arai, S., Ortiz, R., & Garber, A. M. (2007). A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 25(6), 634–41.

Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage
Ghanouni, P., Kurian, A. W., Margolis, D., Hartman, A.-R., Mills, M. A., Plevritis, S. K., … Daniel, B. L. (2007). Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage. BREAST JOURNAL, 13(3), 281–86.

CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer
Norton, J. A., Ham, C. M., Van Dam, J., Jeffrey, R. B., Longacre, T. A., Huntsman, D. G., … Ford, J. M. (2007). CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer. ANNALS OF SURGERY, 245(6), 873–79.

Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers
Staton, A. D., Kurian, A. W., Cobb, K., Mills, M. A., & Ford, J. M. (2008). Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. FAMILIAL CANCER, 7(2), 179–86.

A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature
Ghataorhe, P., Kurian, A. W., Pickart, A., Trapane, P., Norton, J. A., Kingham, K., & Ford, J. M. (2007). A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature. CANCER GENETICS AND CYTOGENETICS, 179(2), 89–92.

Magnetic resonance galactography: A feasibility study in women with prior atypical breast duct cytology
Kurian, A. W., Hartman, A.-R., Mills, M. A., Logan, L. J., Sawyer, A. M., Ford, J. M., & Daniel, B. L. (2008). Magnetic resonance galactography: A feasibility study in women with prior atypical breast duct cytology. BREAST JOURNAL, 14(2), 211–14.

The Decline in Breast Cancer Incidence: Real or Imaginary?
Kurian, A. W., Clarke, C. A., & Carlson, R. W. (2009). The Decline in Breast Cancer Incidence: Real or Imaginary? CURRENT ONCOLOGY REPORTS, 11(1), 21–28.

Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry
Kurian, A. W., Gong, G. D., John, E. M., Miron, A., Felberg, A., Phipps, A. I., … Whittemore, A. S. (2009). Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 18(4), 1084–91.

Second Primary Breast Cancer Occurrence According to Hormone Receptor Status
Kurian, A. W., McClure, L. A., John, E. M., Horn-Ross, P. L., Ford, J. M., & Clarke, C. A. (2009). Second Primary Breast Cancer Occurrence According to Hormone Receptor Status. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 101(15), 1058–65.

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Kurian, A. W. (2010). BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 22(1), 72–78.

Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers
Kurian, A. W., Sigal, B. M., & Plevritis, S. K. (2010). Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers. JOURNAL OF CLINICAL ONCOLOGY, 28(2), 222–31.

Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California
Gomez, S. L., Lichtensztajn, D., Kurian, A. W., Telli, M. L., Chang, E. T., Keegan, T. H. M., … Clarke, C. A. (2010). Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California. JOURNAL OF CLINICAL ONCOLOGY, 28(10), E155–E157.

High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients
Kwong, A., Ng, E. K. O., Law, F. B. F., Wong, L. P., To, M. Y., Cheung, M. T., … Ma, E. S. K. (2010). High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 122(2), 605–7.

Genetic/familial high-risk assessment: breast and ovarian.
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., … Weitzel, J. N. (2010). Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network , 8(5), 562–594.

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry
Telli, M. L., Chang, E. T., Kurian, A. W., Keegan, T. H. M., McClure, L. A., Lichtensztajn, D., … Gomez, S. L. (2011). Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. BREAST CANCER RESEARCH AND TREATMENT, 127(2), 471–78.

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups
Kurian, A. W., Fish, K., Shema, S. J., & Clarke, C. A. (2010). Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. BREAST CANCER RESEARCH, 12(6).

A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
Chen, Y., Kingham, K., Ford, J. M., Rosing, J., Van Dam, J., Jeffrey, R. B., … Norton, J. A. (2011). A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer. ANNALS OF SURGICAL ONCOLOGY, 18(9), 2594–98.

Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry
Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., West, D. W., … Whittemore, A. S. (2011). Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry. JOURNAL OF CLINICAL ONCOLOGY, 29(34), 4505–9.

Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers
Kurian, A. W., Munoz, D. F., Rust, P., Schackmann, E. A., Smith, M., Clarke, L., … Plevritis, S. K. (2012). Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers. JOURNAL OF CLINICAL ONCOLOGY, 30(5), 497–506.

Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort
Kwong, A., Wong, C. H. N., Suen, D. T. K., Co, M., Kurian, A. W., West, D. W., & Ford, J. M. (2012). Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort. WORLD JOURNAL OF SURGERY, 36(4), 702–13.

Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early-Stage Breast Cancer among Asian American Women in California
Gomez, S. L., Press, D. J., Lichtensztajn, D., Keegan, T. H. M., Shema, S. J., Le, G. M., & Kurian, A. W. (2012). Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early-Stage Breast Cancer among Asian American Women in California. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(5), 821–834.

Occurrence of breast cancer subtypes in adolescent and young adult women
Keegan, T. H. M., DeRouen, M. C., Press, D. J., Kurian, A. W., & Clarke, C. A. (2012). Occurrence of breast cancer subtypes in adolescent and young adult women. BREAST CANCER RESEARCH, 14(2).

Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease.
Vinayak, S., & Kurian, A. W. (2009). Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease. Current Breast Cancer Reports, 1(3), 148–56.

A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers
Sigal, B. M., Munoz, D. F., Kurian, A. W., & Plevritis, S. K. (2012). A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(7), 1066–77.

Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Powell, A. A., Talasaz, A. A. H., Zhang, H., Coram, M. A., Reddy, A., Deng, G., … Jeffrey, S. S. (2012). Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines. PLOS ONE, 7(5).

Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations
de Bruin, M. A., Kwong, A., Goldstein, B. A., Lipson, J. A., Ikeda, D. M., McPherson, L., … Kurian, A. W. (2012). Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations. FAMILIAL CANCER, 11(3), 429–39.

Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover
Clarke, C. A., Keegan, T. H. M., Yang, J., Press, D. J., Kurian, A. W., Patel, A. H., & Lacey, J. V. (2012). Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 104(14), 1094–1101.

Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis
Kwong, A., Ng, E. K. O., Wong, C. L. P., Law, F. B. F., Au, T., Wong, H. N., … Ma, E. S. K. (2012). Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis. PLOS ONE, 7(9).

Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers
Schackmann, E. A., Munoz, D. F., Mills, M. A., Plevritis, S. K., & Kurian, A. W. (2013). Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers. FAMILIAL CANCER, 12(1), 65–73.

Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients
Kwong, A., Ng, E. K. O., Law, F. B. F., Wong, H. N., Wa, A., Wong, C. L. P., … Ma, E. S. K. (2012). Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 136(3), 931–33.

Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007
Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. H. M., Leung, R. W., Shema, S. J., Hershman, D. L., … Gomez, S. L. (2013). Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. BREAST CANCER RESEARCH AND TREATMENT, 137(1), 247–60.

Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research.
Weber, S. C., Seto, T., Olson, C., Kenkare, P., Kurian, A. W., & Das, A. K. (2012). Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research. AMIA ... Annual Symposium Proceedings / AMIA Symposium. AMIA Symposium, 2012, 970–78.

A young woman with bilateral breast cancer: identifying a genetic cause and implications for management.
de Bruin, M. A., Ford, J. M., & Kurian, A. W. (2013). A young woman with bilateral breast cancer: identifying a genetic cause and implications for management. Journal of the National Comprehensive Cancer Network , 11(5), 512–17.

Hereditary cancer: counseling women at risk
Lebensohn, A. P., Kingham, K. E., Chun, N. M., & Kurian, A. W. (2011). Hereditary cancer: counseling women at risk. CONTEMPORARY OBSTETRICS AND GYNECOLOGY, 56(4).

Information technology interventions to improve cancer care: a report from the American Society of Clinical Oncology Quality Care Symposium
Kurian, A. W., & Edge, S. B. (2013). Information technology interventions to improve cancer care: a report from the American Society of Clinical Oncology Quality Care Symposium. JOURNAL OF ONCOLOGY PRACTICE, 9(3).

Biomedical terahertz imaging with a quantum cascade laser
Kim, S. M., Hatami, F., Harris, J. S., Kurian, A. W., Ford, J., King, D., … Harris, G. (2006). Biomedical terahertz imaging with a quantum cascade laser. APPLIED PHYSICS LETTERS, 88(15).

The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival
Wu, A. H., Gomez, S. L., Vigen, C., Kwan, M. L., Keegan, T. H. M., Lu, Y., … Sposto, R. (2013). The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. CANCER CAUSES & CONTROL, 24(10), 1821–36.

The California Breast Density Information Group: A Collaborative Response to the Issues of Breast Density, Breast Cancer Risk, and Breast Density Notification Legislation
Price, E. R., Hargreaves, J., Lipson, J. A., Sickles, E. A., Brenner, R. J., Lindfors, K. K., … Ikeda, D. M. (2013). The California Breast Density Information Group: A Collaborative Response to the Issues of Breast Density, Breast Cancer Risk, and Breast Density Notification Legislation. RADIOLOGY, 887–92.

Impact of breast cancer subtypes on three-year survival among adolescent and young adult women
Keegan, T. H. M., Press, D. J., Tao, L., DeRouen, M. C., Kurian, A. W., Clarke, C. A., & Gomez, S. L. (2013). Impact of breast cancer subtypes on three-year survival among adolescent and young adult women. BREAST CANCER RESEARCH, 15(5).

A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk
Vinayak, S., Schwartz, E. J., Jensen, K., Lipson, J., Alli, B., McPherson, L., … Kurian, A. W. (2013). A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. BREAST CANCER RESEARCH AND TREATMENT, electronic publication ahead of print, October 30.

Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research.
Kurian, A. W., Mitani, A., Desai, M., Yu, P. P., Seto, T., Weber, S. C., … Das, A. K. (2014). Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Cancer, 120(1), 103–11.

Obesity and Mortality After Breast Cancer by Race/Ethnicity: The California Breast Cancer Survivorship Consortium
Kwan, M. L., John, E. M., Caan, B. J., Lee, V. S., Bernstein, L., Cheng, I., … Wu, A. H. (2014). Obesity and Mortality After Breast Cancer by Race/Ethnicity: The California Breast Cancer Survivorship Consortium. AMERICAN JOURNAL OF EPIDEMIOLOGY, 179(1), 95–111.

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., … Ford, J. M. (2014). Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. JOURNAL OF CLINICAL ONCOLOGY, 32(19), 2001–9.

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014
Daly, M. B., Pilarski, R., Axilbund, J. E., Buys, S. S., Crawford, B., Friedman, S., … Kumar, R. (2014). Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(9), 1326–38.

Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. H. M., Nelson, D. O., Clarke, C. A., & Gomez, S. L. (2014). Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. JAMA-the Journal of the American Medical Association, 312(9), 902–914.

Beyond barriers: fundamental 'disconnects' underlying the treatment of breast cancer patients' sexual health
Halley, M. C., May, S. G., Rendle, K. A. S., Frosch, D. L., & Kurian, A. W. (2014). Beyond barriers: fundamental 'disconnects' underlying the treatment of breast cancer patients' sexual health. CULTURE HEALTH & SEXUALITY, 16(9), 1169–80.

Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC).
Wu, A. H., Kurian, A. W., Kwan, M. L., John, E. M., Lu, Y., Keegan, T. H. M., … Vigen, C. (2015). Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 24(2), 361–68.

Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
Kurian, A. W., Kingham, K. E., & Ford, J. M. (2015). Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment. Current Opinion in Obstetrics & Gynecology, 27(1), 23–33.

How can we best respect patient autonomy in breast cancer treatment decisions?
Martinez, K. A., Kurian, A. W., Hawley, S. T., & Jagsi, R. (2015). How can we best respect patient autonomy in breast cancer treatment decisions? Breast Cancer Management, 4(1), 53–64.

Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System
Keegan, T. H. M., Kurian, A. W., Gali, K., Tao, L., Lichtensztajn, D. Y., Hershman, D. L., … Gomez, S. L. (2015). Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System. AMERICAN JOURNAL OF PUBLIC HEALTH, 105(5), 938–46.

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.
Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., Graff, J. J., … Hawley, S. T. (2015). Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. Journal of Clinical Oncology , 33(14), 1584–91.

Multiple-Gene Panels and the Future of Genetic Testing
Kurian, A. W., & Ford, J. M. (2015). Multiple-Gene Panels and the Future of Genetic Testing. Current Breast Cancer Reports.

History of Recreational Physical Activity and Survival After Breast Cancer The California Breast Cancer Survivorship Consortium
Lu, Y., John, E. M., Sullivan-Halley, J., Vigen, C., Gomez, S. L., Kwan, M. L., … Bernstein, L. (2015). History of Recreational Physical Activity and Survival After Breast Cancer The California Breast Cancer Survivorship Consortium. AMERICAN JOURNAL OF EPIDEMIOLOGY, 181(12), 944–55.

Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
Tao, L., Gomez, S. L., Keegan, T. H. M., Kurian, A. W., & Clarke, C. A. (2015). Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 24(7), 1039–45.

Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium
Cheng, I., Shariff-Marco, S., Koo, J., Monroe, K. R., Yang, J., John, E. M., … Keegan, T. H. M. (2015). Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24(8), 1282–90.

Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer
Shariff-Marco, S., Yang, J., John, E. M., Kurian, A. W., Cheng, I., Leung, R., … Gomez, S. L. (2015). Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. JOURNAL OF COMMUNITY HEALTH, 40(6), 1287–99.

Breast Cancer Risk Reduction, Version 2.2015
Bevers, T. B., Ward, J. H., Arun, B. K., Colditz, G. A., Cowan, K. H., Daly, M. B., … Kumar, R. (2015). Breast Cancer Risk Reduction, Version 2.2015. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(7), 880–915.

Multigene Panel Testing in Oncology Practice: How Should We Respond?
Kurian, A. W., & Ford, J. M. (2015). Multigene Panel Testing in Oncology Practice: How Should We Respond? JAMA Oncology, 1(3), 277–78.

Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries
Kwong, A., Shin, V. Y., Ho, J. C. W., Kang, E., Nakamura, S., Teo, S.-H., … Kim, S.-W. (2016). Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. JOURNAL OF MEDICAL GENETICS, 53(1), 15–23.

Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.
Katz, S. J., Kurian, A. W., & Morrow, M. (2015). Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations. JAMA.

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients
Lincoln, S. E., Kobayashi, Y., Anderson, M. J., Yang, S., Desmond, A. J., Mills, M. A., … Ellisen, L. W. (2015). A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. JOURNAL OF MOLECULAR DIAGNOSTICS, 17(5), 533–44.

A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer
DeRouen, M. C., Gomez, S. L., Press, D. J., Tao, L., Kurian, A. W., & Keegan, T. H. M. (2013). A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2(3), 95–103.

Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact.
Kurian, A. W., & Friese, C. R. (2015). Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact. JAMA Oncology.

Reply to S.M. Sorscher and A.B. Hafeez Bhatti.
Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., Graff, J. J., … Hawley, S. T. (2015). Reply to S.M. Sorscher and A.B. Hafeez Bhatti. Journal of Clinical Oncology , 33(35), 4233-?

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
Telli, M. L., Jensen, K. C., Vinayak, S., Kurian, A. W., Lipson, J. A., Flaherty, P. J., … Ford, J. M. (2015). Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105. JOURNAL OF CLINICAL ONCOLOGY, 33(17), 1895–U57.

Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer
Afghahi, A., Forgo, E., Mitani, A. A., Desai, M., Varma, S., Seto, T., … West, R. B. (2015). Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. BREAST CANCER RESEARCH, 17.

Navigating choices when applying multiple imputation in the presence of multi-level categorical interaction effects
Mitani, A. A., Kurian, A. W., Das, A. K., & Desai, M. (2015). Navigating choices when applying multiple imputation in the presence of multi-level categorical interaction effects. STATISTICAL METHODOLOGY, 27, 82–99.

Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).
Vigen, C., Kwan, M. L., John, E. M., Gomez, S. L., Keegan, T. H. M., Lu, Y., … Wu, A. H. (2016). Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Causes & Control , 27(3), 391–401.

Addressing Inherited Predisposition for Breast Cancer in Transplant Recipients
Yang, R. L., Kurian, A. W., Winton, L. M., Weill, D., Patel, K., Kingham, K., & Wapnir, I. L. (2016). Addressing Inherited Predisposition for Breast Cancer in Transplant Recipients. JOURNAL OF SURGICAL ONCOLOGY, 113(6), 605–8.

The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality
Sposto, R., Keegan, T. H. M., Vigen, C., Kwan, M. L., Bernstein, L., John, E. M., … Wu, A. H. (2016). The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 25(7), 1064–72.

Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.
Afghahi, A., Mathur, M., Thompson, C. A., Mitani, A., Rigdon, J., Desai, M., … Kurian, A. W. (2016). Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems. Journal of Oncology Practice / American Society of Clinical Oncology, 12(6), e697–709.

Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information.
Kurian, A. W., Antoniou, A. C., & Domchek, S. M. (2016). Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information. American Society of Clinical Oncology Educational Book / ASCO. American Society of Clinical Oncology. Meeting, 35, 44–56.

Association of non-melanoma skin cancer with second non-cutaneous malignancy in the Women's Health Initiative.
Ransohoff, K. J., Stefanick, M. L., Li, S., Kurian, A. W., Wakelee, H., Wang, A., … Tang, J. Y. (2016). Association of non-melanoma skin cancer with second non-cutaneous malignancy in the Women's Health Initiative. The British Journal of Dermatology.

Statin use and all-cancer survival: prospective results from the Women's Health Initiative
Wang, A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. A. E., Chlebowski, R. T., … Stefanick, M. L. (2016). Statin use and all-cancer survival: prospective results from the Women's Health Initiative. BRITISH JOURNAL OF CANCER, 115(1), 129–35.

Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population.
Tao, L., Chu, L., Wang, L. I., Moy, L., Brammer, M., Song, C., … Clarke, C. A. (2016). Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population. Cancer Causes & Control , 27(9), 1127–38.

Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012.
Wapnir, I. L., Kurian, A. W., Lichtensztajn, D. Y., Clarke, C. A., & Gomez, S. L. (2016). Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012. Annals of Surgery, -?

Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013.
Kurian, A. W., Canchola, A. J., Gomez, S. L., & Clarke, C. A. (2016). Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013. Breast Cancer Research and Treatment, 160(2), 333–38.

Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?
Wang, A., Wakelee, H. A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. A. E., & Stefanick, M. L. (2016). Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients? Current Atherosclerosis Reports, 18(12), 72-?

Reply to Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'.
Wang, A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. A. E., Chlebowski, R. T., … Stefanick, M. L. (2017). Reply to Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'. British Journal of Cancer, 116(3).

The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence
Janz, N. K., Li, Y., Zikmund-Fisher, B. J., Jagsi, R., Kurian, A. W., An, L. C., … Hawley, S. T. (2017). The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence. BREAST CANCER RESEARCH AND TREATMENT, 161(3), 525–35.

Synergistic drug combinations from electronic health records and gene expression.
Low, Y. S., Daugherty, A. C., Schroeder, E. A., Chen, W., Seto, T., Weber, S., … Shah, N. H. (2016). Synergistic drug combinations from electronic health records and gene expression. Journal of the American Medical Informatics Association .

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015 Featured Updates to the NCCN Guidelines
Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., … Darlow, S. (2016). Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 14(2), 153–62.

Recurrence risk perception and quality of life following treatment of breast cancer
Hawley, S. T., Janz, N. K., Griffith, K. A., Jagsi, R., Friese, C. R., Kurian, A. W., … Katz, S. J. (2017). Recurrence risk perception and quality of life following treatment of breast cancer. BREAST CANCER RESEARCH AND TREATMENT, 161(3), 557–65.

The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients
Li, Y., Kurian, A. W., Bondarenko, I., Taylor, J. M. G., Jagsi, R., Ward, K. C., … Hofer, T. P. (2017). The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 161(3), 587–95.

Unsupervised clustering of quantitative image phenotypes reveals breast cancer subtypes with distinct prognoses and molecular pathways.
Wu, J., Cui, Y., Sun, X., Cao, G., Li, B., Ikeda, D. M., … Li, R. (2017). Unsupervised clustering of quantitative image phenotypes reveals breast cancer subtypes with distinct prognoses and molecular pathways. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

Tumor BRCA1 Reversion Mutation Arising During Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.
Afghahi, A., Timms, K. M., Vinayak, S., Jensen, K. C., Kurian, A. W., Carlson, R. W., … Telli, M. L. (2017). Tumor BRCA1 Reversion Mutation Arising During Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

Treatment-associated toxicities reported by patients with early-stage invasive breast cancer.
Friese, C. R., Harrison, J. M., Janz, N. K., Jagsi, R., Morrow, M., Li, Y., … Hofer, T. P. (2017). Treatment-associated toxicities reported by patients with early-stage invasive breast cancer. Cancer.

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
Kurian, A. W., Griffith, K. A., Hamilton, A. S., Ward, K. C., Morrow, M., Katz, S. J., & Jagsi, R. (2017). Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer . JAMA, 317(5), 531–34.

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
Trosman, J. R., Weldon, C. B., Douglas, M. P., Kurian, A. W., Kelley, R. K., Deverka, P. A., & Phillips, K. A. (2017). Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative. Journal of the National Comprehensive Cancer Network : JNCCN, 15(2), 219–28.

Dynamic Strategy for Personalized Medicine: An Application to Metastatic Breast Cancer.
Chen, X., Shachter, R., Kurian, A., & Rubin, D. (2017). Dynamic Strategy for Personalized Medicine: An Application to Metastatic Breast Cancer. Journal of Biomedical Informatics.

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Kurian, A. W., Li, Y., Hamilton, A. S., Ward, K. C., Hawley, S. T., Morrow, M., … Katz, S. J. (2017). Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer. Journal of Clinical Oncology , JCO2016716480-?

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., Kobayashi, Y., … Ellisen, L. (2015). Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. JAMA ONCOLOGY, 1(7), 943–51.

NCCN Guidelines (R) Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., … Darlow, S. (2017). NCCN Guidelines (R) Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 15(1), 9–19.

Genetics of triple-negative breast cancer: Implications for patient care
Afghahi, A., Telli, M. L., & Kurian, A. W. (2016). Genetics of triple-negative breast cancer: Implications for patient care. CURRENT PROBLEMS IN CANCER, 40(2-4), 130–40.

Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management.
Morrow, M., Abrahamse, P., Hofer, T. P., Ward, K. C., Hamilton, A. S., Kurian, A. W., … Jagsi, R. (2017). Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management. JAMA Oncology.

Chemotherapy Decisions and Patient Experience With the Recurrence Score Assay for Early-Stage Breast Cancer
Friese, C. R., Li, Y., Bondarenko, I., Hofer, T. P., Ward, K. C., Hamilton, A. S., … Katz, S. J. (2017). Chemotherapy Decisions and Patient Experience With the Recurrence Score Assay for Early-Stage Breast Cancer. CANCER, 123(1), 43–51.

Second Opinions From Medical Oncologists for Early-Stage Breast Cancer Prevalence, Correlates, and Consequences
Kurian, A. W., Friese, C. R., Bondarenko, I., Jagsi, R., Li, Y., Hamilton, A. S., … Katz, S. J. (2017). Second Opinions From Medical Oncologists for Early-Stage Breast Cancer Prevalence, Correlates, and Consequences. JAMA ONCOLOGY, 3(3), 391–97.

Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer
Jagsi, R., Hawley, S. T., Griffith, K. A., Janz, N. K., Kurian, A. W., Ward, K. C., … Katz, S. J. (2017). Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer. JAMA SURGERY, 152(3).

The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
Afghahi, A., & Kurian, A. W. (2017). The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition. Current Treatment Options in Oncology, 18(5), 27-?

Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
Katz, S. J., Hawley, S. T., Bondarenko, I., Jagsi, R., Ward, K. C., Hofer, T. P., & Kurian, A. W. (2017). Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer? Breast Cancer Research and Treatment.

Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
Wu, J., Li, B., Sun, X., Cao, G., Rubin, D. L., Napel, S., … Li, R. (2017). Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer. Radiology, 162823.

Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
Caswell-Jin, J. L., Gupta, T., Hall, E., Petrovchich, I. M., Mills, M. A., Kingham, K. E., … Kurian, A. W. (2017). Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genetics in Medicine : Official Journal of the American College of Medical Genetics.

What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?
Lee, K. L., Janz, N. K., Zikmund-Fisher, B. J., Jagsi, R., Wallner, L. P., Kurian, A. W., … Hawley, S. T. (2017). What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment? Medical Decision Making : an International Journal of the Society for Medical Decision Making, 272989X17724441.

Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks.
Lin, C.-Y. Y., Carneal, E. E., Lichtensztajn, D. Y., Gomez, S. L., Clarke, C. A., Jensen, K. C., … Allison, K. H. (2017). Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks. American Journal of Clinical Pathology, 148(3), 199–207.

Treatment decisions and employment of breast cancer patients: Results of a population-based survey.
Jagsi, R., Abrahamse, P. H., Lee, K. L., Wallner, L. P., Janz, N. K., Hamilton, A. S., … Katz, S. J. (2017). Treatment decisions and employment of breast cancer patients: Results of a population-based survey. Cancer.

Performance of BRCA1/2 mutation prediction models in Asian Americans
Kurian, A. W., Gong, G. D., Chun, N. M., Mills, M. A., Staton, A. D., Kingham, K. E., … Ford, J. M. (2008). Performance of BRCA1/2 mutation prediction models in Asian Americans. JOURNAL OF CLINICAL ONCOLOGY, 26(29).

Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
Kurian, A. W., Bondarenko, I., Jagsi, R., Friese, C. R., McLeod, M. C., Hawley, S. T., … Katz, S. J. (2017). Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer. Journal of the National Cancer Institute.

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
Plevritis, S. K., Munoz, D., Kurian, A. W., Stout, N. K., Alagoz, O., Near, A. M., … Mandelblatt, J. S. (2018). Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012. JAMA, 319(2), 154–64.

Patient communication of cancer genetic test results in a diverse population.
Ricker, C. N., Koff, R. B., Qu, C., Culver, J., Sturgeon, D., Kingham, K. E., … Idos, G. E. (2018). Patient communication of cancer genetic test results in a diverse population. Translational Behavioral Medicine, 8(1), 85–94.

Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.
Shumway, D. A., McLeod, C. M., Morrow, M., Li, Y., Kurian, A. W., Sabolch, A., … Jagsi, R. (2018). Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ. International Journal of Radiation Oncology, Biology, Physics.

Rapid detection ofBRCA1/2recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels.
Kwong, A., Ho, J. C., Shin, V. Y., Kurian, A. W., Tai, E., Esserman, L. J., … Ford, J. M. (2018). Rapid detection ofBRCA1/2recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels. Oncotarget, 9(8), 7832–43.

Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
Katz, S. J., Ward, K. C., Hamilton, A. S., Mcleod, M. C., Wallner, L. P., Morrow, M., … Kurian, A. W. (2018). Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017762369.

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.
Mandelblatt, J. S., Near, A. M., Miglioretti, D. L., Munoz, D., Sprague, B. L., Trentham-Dietz, A., … Plevritis, S. K. (2018). Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling. Medical Decision Making : an International Journal of the Society for Medical Decision Making, 38(1_suppl), 9S–23S.

Differences in Breast Cancer Survival by Molecular Subtypes in the United States.
Howlader, N., Cronin, K. A., Kurian, A. W., & Andridge, R. (2018). Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.
Chu, L. W., John, E. M., Yang, B., Kurian, A. W., Zia, Y., Yu, K., … Hsing, A. W. (2018). Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies. PloS One, 13(4), e0195666.

Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.
Katz, S. J., Bondarenko, I., Ward, K. C., Hamilton, A. S., Morrow, M., Kurian, A. W., & Hofer, T. P. (2018). Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer. JAMA Surgery.

Statin use and all-cancer mortality: Prospective results from the Women's Health Initiative
Wang, A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. A. E., Chlebowski, R. T., … Stefanick, M. L. (2015). Statin use and all-cancer mortality: Prospective results from the Women's Health Initiative. JOURNAL OF CLINICAL ONCOLOGY, 33(15).

Unmet Need for Clinician Engagement Regarding Financial Toxicity After Diagnosis of Breast Cancer.
Jagsi, R., Ward, K. C., Abrahamse, P. H., Wallner, L. P., Kurian, A. W., Hamilton, A. S., … Hawley, S. T. (2018). Unmet Need for Clinician Engagement Regarding Financial Toxicity After Diagnosis of Breast Cancer. Cancer.

Chromosomal copy number alterations (CNAs) for risk assessment of ductal carcinoma in situ (DCIS)
Afghahi, A., Forgo, E., Mitani, A., Desai, M., Varma, S., Seto, T., … West, R. B. (2014). Chromosomal copy number alterations (CNAs) for risk assessment of ductal carcinoma in situ (DCIS). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging.
Keren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., … Angelo, M. (2018). A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. Cell, 174(6), 1373.

Lymphopenia after adjuvant radiotherapy (RT) to predict poor survival in triple-negative breast cancer (TNBC).
Afghahi, A., Mathur, M., Seto, T., Desai, M., Kenkare, P., Horst, K. C., … Sledge, G. W. (2015). Lymphopenia after adjuvant radiotherapy (RT) to predict poor survival in triple-negative breast cancer (TNBC). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial.
Gornick, M. C., Kurian, A. W., An, L. C., Fagerlin, A., Jagsi, R., Katz, S. J., & Hawley, S. T. (2018). Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial. Cancer.

COMMUNICATING COMPLEXITY: ANALYSIS OF THE COMMUNICATION OF CANCER GENETIC TEST RESULTS THREE MONTHS POST DISCLOSURE
Ricker, C., Koff, R., Qu, C., Culver, J. O., Sturgeon, D., Lowstuter, K., … Idos, G. (2017). COMMUNICATING COMPLEXITY: ANALYSIS OF THE COMMUNICATION OF CANCER GENETIC TEST RESULTS THREE MONTHS POST DISCLOSURE. ANNALS OF BEHAVIORAL MEDICINE, 51, S1540–S1541.

"The GI Gap" in Genetic Testing for Inherited Susceptibility to Cancer
Idos, G., Kurian, A. W., McDonnell, K., Ricker, C., Sturgeon, D., Culver, J., … Gruber, S. (2015). "The GI Gap" in Genetic Testing for Inherited Susceptibility to Cancer. AMERICAN JOURNAL OF GASTROENTEROLOGY, 110, S606–S607.

Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review
Caswell-Jin, J. L., Plevritis, S. K., Tian, L., Cadham, C. J., Xu, C., Stout, N. K., … Kurian, A. W. (2018). Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review. JNCI Cancer Spectrum, 2(4).

Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations
Kwong, A., Shin, V. Y., Ma, E. S., Chan, C. T., Ford, J. M., Kurian, A. W., & Tai, E. (2018). Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations. Hong Kong Medical Journal, 24.

Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer.
Katz, S. J., Ward, K. C., Hamilton, A. S., Abrahamse, P., Hawley, S. T., & Kurian, A. W. (2018). Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer. JCO Precision Oncology, 2018.

Automatic Inference of BI-RADS Final Assessment Categories from Narrative Mammography Report Findings.
Banerjee, I., Bozkurt, S., Alkim, E., Sagreiya, H., Kurian, A. W., & Rubin, D. L. (2019). Automatic Inference of BI-RADS Final Assessment Categories from Narrative Mammography Report Findings. Journal of Biomedical Informatics, 103137.

Asian-Caucasian differences in BRCA1/2 mutation epidemiology
Kurian, A., Chun, N., Mills, M., Staton, A., Crawford, B., Ridge, Y., … Ford, J. (2007). Asian-Caucasian differences in BRCA1/2 mutation epidemiology. JOURNAL OF WOMENS HEALTH, 16(8), 1110–11.

Molecular receptor profiles in male mutation carriers with breast cancer
Wapnir, I., Kingham, K., Mills, M., Ford, J., & Kurian, A. (2017). Molecular receptor profiles in male mutation carriers with breast cancer. ANNALS OF SURGICAL ONCOLOGY, 24, 112–13.

Genetic Polymorphisms as Predictors of Breast Cancer Risk
de Bruin, M. A., Ford, J. M., & Kurian, A. W. (2012). Genetic Polymorphisms as Predictors of Breast Cancer Risk. CURRENT BREAST CANCER REPORTS, 4(4), 232–39.

Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment
Ellisen, L. W., Kurian, A. W., Desmond, A. J., Mills, M., Lincoln, S. E., Shannon, K. M., … Ford, J. M. (2015). Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment. JOURNAL OF CLINICAL ONCOLOGY, 33(15).

Clinical evaluation of multigene testing for hereditary breast and ovarian cancer
Ellisen, L., Kurian, A., Lincoln, S., Desmond, A., Mills, M., Shannon, K., … Ford, J. (2015). Clinical evaluation of multigene testing for hereditary breast and ovarian cancer. CANCER RESEARCH, 75.

PrECOG 0105: Final efficacy results from a phase II study of gemcitabine (G) and carboplatin (C) plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative (TN) and BRCA1/2 mutation-associated breast cancer
Telli, M. L., Jensen, K. C., Kurian, A. W., Vinayak, S., Lipson, J. A., Schackmann, E. A., … Ford, J. M. (2013). PrECOG 0105: Final efficacy results from a phase II study of gemcitabine (G) and carboplatin (C) plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative (TN) and BRCA1/2 mutation-associated breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 31(15).

Male Breast Cancer: A Comparison Between BRCA Mutation Carriers and Noncarriers in Hong Kong, Southern China
Kwong, A., Chau, W. W., Law, F. B. F., Kurian, A., Ford, J. M., West, D. W., & Ma, E. S. K. (2013). Male Breast Cancer: A Comparison Between BRCA Mutation Carriers and Noncarriers in Hong Kong, Southern China. ANNALS OF SURGICAL ONCOLOGY, 20, 72.

Tailoring BRCAPRO to Asian-Americans IN REPLY
Kurian, A. W., Whittemore, A. S., & Ford, J. M. (2009). Tailoring BRCAPRO to Asian-Americans IN REPLY. JOURNAL OF CLINICAL ONCOLOGY, 27(4), 643–44.

Breast Density Categorization Creep Response
Price, E. R., Hargreaves, J., Lipson, J. A., Sickles, E. A., Brenner, J., Lindfors, K. K., … Ikeda, D. M. (2014). Breast Density Categorization Creep Response. RADIOLOGY, 271(3), 927–28.

Chemotherapy (CTX) treatment patterns for early-stage breast cancer (ESBC): Changing use of anthracyclines (A)
Serrurier, K. M., Hwang, J., McGuire, J. P., Lichtensztajn, D., Griffin, A. C., Gomez, S. L., … Rugo, H. S. (2013). Chemotherapy (CTX) treatment patterns for early-stage breast cancer (ESBC): Changing use of anthracyclines (A). JOURNAL OF CLINICAL ONCOLOGY, 31(15).

Computing the cost of care per day of breast cancer survivor care.
Blayney, D. W., Lindquist, C., Seto, T., Nhat Minh Hoang, & Kurian, A. W. (2018). Computing the cost of care per day of breast cancer survivor care. JOURNAL OF CLINICAL ONCOLOGY, 36(7).

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
Trosman, J. R., Weldon, C. B., Gradishar, W. J., Benson, A. B., Cristofanilli, M., Kurian, A. W., … Phillips, K. A. (2018). From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing. Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 21(9), 1062–1068.

Linking electronic health records to better understand breast cancer patient pathways within and between two health systems.
Thompson, C. A., Kurian, A. W., & Luft, H. S. (2015). Linking electronic health records to better understand breast cancer patient pathways within and between two health systems. EGEMS (Washington, DC), 3(1), 1127.

Pathogenic germline mutations in emerging cancer genes: What happens after panel testing?
Hall, E. T., Parikh, D. A., Gupta, T., Caswell, J. L., Mills, M., Kingham, K., … Kurian, A. W. (2017). Pathogenic germline mutations in emerging cancer genes: What happens after panel testing? JOURNAL OF CLINICAL ONCOLOGY, 35.

Primary care provider-reported involvement in breast cancer treatment decisions
Wallner, L. P., Li, Y., McLeod, M. C., Gargaro, J., Kurian, A. W., Jagsi, R., … Katz, S. J. (2019). Primary care provider-reported involvement in breast cancer treatment decisions. CANCER, 125(11), 1815–22.

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Kurian, A. W., Ward, K. C., Howlader, N., Deapen, D., Hamilton, A. S., Mariotto, A., … Katz, S. J. (2019). Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients. JOURNAL OF CLINICAL ONCOLOGY, 37(15), 1305-+.

Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy
Pollom, E. L., Qian, Y., Chin, A. L., Dirbas, F. M., Asch, S. M., Kurian, A. W., … Tsai, C. J. (2018). Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy. INTERNATIONAL JOURNAL OF CANCER, 143(12), 3262–72.

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer
Afghahi, A., Purington, N., Han, S. S., Desai, M., Pierson, E., Mathur, M. B., … Kurian, A. W. (2018). Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer. CLINICAL CANCER RESEARCH, 24(12), 2851–58.

Expanded yield of multiplex panel testing in fully accrued prospective trial.
Idos, G., Kurian, A. W., Ricker, C. N., Sturgeon, D., Culver, J., Kingham, K., … Gruber, S. B. (2017). Expanded yield of multiplex panel testing in fully accrued prospective trial. JOURNAL OF CLINICAL ONCOLOGY, 35.

Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
Idos, G., Roth, K. G., Naghi, L., Ricker, C. N., Culver, J., Sturgeon, D., … Kurian, A. W. (2017). Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort. JOURNAL OF CLINICAL ONCOLOGY, 35.

Uptake of the 21-Gene Assay Among Women With Node-Positive, Hormone Receptor-Positive Breast Cancer.
Roberts, M. C., Kurian, A. W., & Petkov, V. I. (2019). Uptake of the 21-Gene Assay Among Women With Node-Positive, Hormone Receptor-Positive Breast Cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 17(6), 662–68.

Yield of multiplex panel testing compared to expert opinion and validated prediction models.
Idos, G., Kurian, A. W., Ricker, C. N., Sturgeon, D., Culver, J., Lowstuter, K., … Gruber, S. B. (2016). Yield of multiplex panel testing compared to expert opinion and validated prediction models. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

Safety of multiplex gene testing for inherited cancer risk: Interim analysis of a clinical trial.
Kurian, A. W., Idos, G., Culver, J., Ricker, C. N., Koff, R., Sturgeon, D., … Gruber, S. B. (2016). Safety of multiplex gene testing for inherited cancer risk: Interim analysis of a clinical trial. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer.
Luhn, P., Chui, S. Y., Hsieh, A. F.-C., Yi, J., Mecke, A., Bajaj, P. S., … Kurian, A. W. (2019). Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer. Journal of Comparative Effectiveness Research.

Distribution of Global Health Measures From Routinely Collected PROMIS Surveys in Patients With Breast Cancer or Prostate Cancer
Seneviratne, M. G., Bozkurt, S., Patel, M., Seto, T., Brooks, J. D., Blayney, D. W., … Hernandez-Boussard, T. (2019). Distribution of Global Health Measures From Routinely Collected PROMIS Surveys in Patients With Breast Cancer or Prostate Cancer. CANCER, 125(6), 943–51.

Genomic landscape of ductal carcinoma in situ and association with progression.
Lin, C.-Y. Y., Vennam, S., Purington, N., Lin, E., Varma, S., Han, S., … West, R. B. (2019). Genomic landscape of ductal carcinoma in situ and association with progression. Breast Cancer Research and Treatment.

Chromatin Remodeling in Response to BRCA2-Crisis.
Gruber, J. J., Chen, J., Geller, B., Jäger, N., Lipchik, A. M., Wang, G., … Snyder, M. P. (2019). Chromatin Remodeling in Response to BRCA2-Crisis. Cell Reports, 28(8), 2182–93.e6.

Higher peripheral lymphocyte count to predict survival in triple-negative breast cancer (TNBC).
Afghahi, A., Rigdon, J., Purington, N., Desal, M., Pierson, E., Mathur, M., … Kurian, A. W. (2016). Higher peripheral lymphocyte count to predict survival in triple-negative breast cancer (TNBC). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Relationship between rising bilateral mastectomy rates and increased use of neoadjuvant chemotherapy (NAC) in California, 1998-2012.
Wapnir, I., Kurian, A. W., Lichtensztajn, D., Clarke, C. A., & Gomez, S. L. (2016). Relationship between rising bilateral mastectomy rates and increased use of neoadjuvant chemotherapy (NAC) in California, 1998-2012. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

Use of the 21-gene recurrence score assay (RS) and chemotherapy (CT) across health care (HC) systems.
Afghahi, A., Mitani, A., Desai, M., Yu, P. P., De Bruin, M. A., Seto, T., … Kurian, A. W. (2014). Use of the 21-gene recurrence score assay (RS) and chemotherapy (CT) across health care (HC) systems. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

BRCA1/2 mutations and cancer risk in Asian-Americans
Kurian, A. W., Chun, N. M., & Mills, M. A. (2007). BRCA1/2 mutations and cancer risk in Asian-Americans. Journal of Clinical Oncology, 25(18_suppl), 10512.

The role of BRCA1 in DNA repair and chemosensitivity
Sharma, V. B., Kurian, A. W., Feldman, A.-R., & Ford, J. M. (2007). The role of BRCA1 in DNA repair and chemosensitivity. Journal of Clinical Oncology, 25(18_suppl), 10606.

Predicting US breast cancer mortality rate in the year 2010
Plevritis, S. K., Sigal, B. M., & Kurian, A. W. (2005). Predicting US breast cancer mortality rate in the year 2010. Presented at the American Association for Cancer Research Annual Meeting.

Ductal lavage of non-fluid yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high genetic risk for breast cancer
Kurian, A. W., Mills, M. A., & Nowels, K. W. (2004). Ductal lavage of non-fluid yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high genetic risk for breast cancer. Journal of Clinical Oncology, (14_suppl), 9535.

Comparative Analysis of Bio-Medical Imaging at 3.7 Terahertz with a High Power Quantum Cascade Laser
Kim, S. M., Hatami, F., Gu, A., & Kurian, A. W. (2006). Comparative Analysis of Bio-Medical Imaging at 3.7 Terahertz with a High Power Quantum Cascade Laser. IEEE, 231.

Identification of ductal atypia with MR galactography
Hartman, A.-R., Mills, M. A., Kurian, A. W., Ford, J. M., Smith, D. N., & Daniel, B. L. (2004). Identification of ductal atypia with MR galactography. Journal of Clinical Oncology, 22(14_suppl), 1035.

A phase II breast cancer chemoprevention study of lovastatin in high-risk women: Initial feasibility data
Kurian, A. W., Sharma, V. B., & Schwartz, E. J. (2007). A phase II breast cancer chemoprevention study of lovastatin in high-risk women: Initial feasibility data. Journal of Clinical Oncology, 25(18_suppl), 1502.

Breast cancer risk management choices by women with inherited breast cancer predisposition: a preliminary analysis
Kurian, A. W., Hartman, A.-R., & Mills, M. A. (2005). Breast cancer risk management choices by women with inherited breast cancer predisposition: a preliminary analysis. Breast Cancer Research and Treatment, 94.

Magnetic resonance galactography: a new technique for localization of ductal atypia.
Hartman, A.-R., Kurian, A. W., & Mills, M. A. (2004). Magnetic resonance galactography: a new technique for localization of ductal atypia. Breast Cancer Research and Treatment, 88, S190.

Asian-Caucasian differences in BRCA1/2 mutation epidemiology
Kurian, A. W., Chun, N. M., & Mills, M. A. (2007). Asian-Caucasian differences in BRCA1/2 mutation epidemiology. Journal of Women's Health, 16(8), 1110–11.

More than a Moment: The Role of Significant Others in Medical Decision Making
May, S., Rendle, K., Ventre, N., Kurian, A. W., & Frosch, D. (2011). More than a Moment: The Role of Significant Others in Medical Decision Making. INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 10(4), 488–89.

Estimating the life years gained from breast MRI screening in women with BRCA1/2 mutations
Plevritis, S. K., Sigal, B. M., & Kurian, A. W. (2005). Estimating the life years gained from breast MRI screening in women with BRCA1/2 mutations. Presented at the The 27th Annual Meeting of the Society for Medical Decision Making.

A time to decide: patient perspectives on breast cancer treatment decision making
May, S., Rendle, K., Ventre, N., Kurian, A. W., & Frosch, D. (2011). A time to decide: patient perspectives on breast cancer treatment decision making. INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 10, 456.

A clinic-based study of BRCA1/2 mutation epidemiology in Asians
Kurian, A. W., Chun, N. M., & Millls, M. A. (2006). A clinic-based study of BRCA1/2 mutation epidemiology in Asians. Breast Cancer Research and Treatment, 100.

Male breast cancer: a comparison between BRCA mutation carriers and non-carriers in Hong Kong, Southern China
Kwong, A., Chau, W. W., Law, F., & Kurian, A. W. (2013). Male breast cancer: a comparison between BRCA mutation carriers and non-carriers in Hong Kong, Southern China. ASBrS Official Proceedings.

Results from a pilot breast cancer screening trial using a combination of clincal breast exam, mammography, breast MRI, and ductal lavage in a high-risk population
Hartman, A.-R., Kurian, A. W., & Mills, M. A. (2003). Results from a pilot breast cancer screening trial using a combination of clincal breast exam, mammography, breast MRI, and ductal lavage in a high-risk population. Breast Cancer Research and Treatment, 82.

A pilot breast cancer screening trial for women at high inherited risk using clinical breast exam, mammography, breast magnetic resonance imaging, and ductal lavage: updated results after median follow-up of fourteen months
Kurian, A. W., Daniel, B. L., & Mills, M. A. (2004). A pilot breast cancer screening trial for women at high inherited risk using clinical breast exam, mammography, breast magnetic resonance imaging, and ductal lavage: updated results after median follow-up of fourteen months. Breast Cancer Research and Treatment, 88.

Beyond Barriers: Systemic Constraints Limiting Sexual Health Care for Breast Cancer Survivors
Halley, M., May, S., Rendle, K., Frosch, D., & Kurian, A. W. (2013). Beyond Barriers: Systemic Constraints Limiting Sexual Health Care for Breast Cancer Survivors. Clinical Medicine & Research, 11(3), 133.

The California Breast Cancer Survivorship Consortium: Prognostic factors associated with racial/ethnic differences in breast cancer survival
Vigen, C., Gomez, S. L., Sposto, R., Lu, Y., Kwan, M., John, E., … Kurian, A. W. (2012). The California Breast Cancer Survivorship Consortium: Prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Prevention Research, 5(11_suppl), A04.

A Phase II Study of Gemcitabine and Carboplatin Plus Iniparib (BSI-201) as Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer.
Telli, M. L., Kurian, A. W., & Jensen, K. C. (2011). A Phase II Study of Gemcitabine and Carboplatin Plus Iniparib (BSI-201) as Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer. Presented at the San Antonio Breast Cancer Symposium.

HER2 Positive Rates Vary by County and Geographic Region in California Independent of Stage and Age at Presentation
Allison, K. H., Jensen, K. C., Dur, C. C., Gomez, S. L., West, R. W., & Kurian, A. W. (2014). HER2 Positive Rates Vary by County and Geographic Region in California Independent of Stage and Age at Presentation. LABORATORY INVESTIGATION, 94, 34A–35A.

Utilizing BRCA1/2 mutation status to select patients for breast cancer clinical trials: Experience from a prospective phase II trial.
Schackmann, E. A., Vinayak, S., & Kurian, A. W. (2011). Utilizing BRCA1/2 mutation status to select patients for breast cancer clinical trials: Experience from a prospective phase II trial. Journal of Clinical Oncology, 29(27_suppl), 161.

Variation in HER2 positive rates in California by geographic region: Implications for setting pathology laboratory benchmarks
Allison, K. H., Jensen, K., West, R., Clarke, C. A., Gomez, S. L., & Kurian, A. W. (2013). Variation in HER2 positive rates in California by geographic region: Implications for setting pathology laboratory benchmarks. Presented at the San Antonio Breast Cancer Symposium.

Impact of California breast density notification law SB 1538 on California women and their health care providers
Ikeda, D. M., Thomas, W. R., Joe, B. N., Lindfors, K., Brenner, R. J., Feig, S., … Kurian, A. W. (2013). Impact of California breast density notification law SB 1538 on California women and their health care providers. Presented at the American Association for Cancer Research Annual Meeting.

The impact of “significant others” on breast cancer patients’ treatment decision making.
May, S., Rendle, K., Halley, M., Ventre, N., Kurian, A. W., & Yu, P. P. (2012). The impact of “significant others” on breast cancer patients’ treatment decision making. Presented at the ASCO Breast Cancer Symposium.

PrECOG 0105: Final efficacy results from a phase II study of gemcitabine and carboplatin plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative and BRCA1/2 mutation-associated breast cancer
Telli, M. L., Jensen, K., & Kurian, A. W. (2013). PrECOG 0105: Final efficacy results from a phase II study of gemcitabine and carboplatin plus iniparib (BSI-201) as neoadjuvant therapy for triple-negative and BRCA1/2 mutation-associated breast cancer. Presented at the American Society of Clinical Oncology Annual Meeting.

A High Percentage of Triple Negative Tumors Present as Palpable Masses
Kalu, O. N., Kurian, A. W., & Wapnir, I. L. (2010). A High Percentage of Triple Negative Tumors Present as Palpable Masses. Presented at the San Antonio Breast Cancer Symposium.

The Accuracy of BRCA1/2 Mutation Prediction Models in Different Ethnicity and Gender: Experience in a Chinese Cohort
Kwong, A., Wong, C. H. N., Suen, D. T. K., Choi, C. L. Y., Wong, C. L. P., Law, F. F. B., & Kurian, A. W. (2010). The Accuracy of BRCA1/2 Mutation Prediction Models in Different Ethnicity and Gender: Experience in a Chinese Cohort. Presented at the San Antonio Breast Cancer Symposium.

Breast Cancer Risk Factors among Asian Versus Caucasian Women with BRCA1/2 Mutations.
de Bruin, M., Kwong, A., Goldstein, B. L., Lipson, J., Ikeda, D., McPherson, L., … Kurian, A. W. (2011). Breast Cancer Risk Factors among Asian Versus Caucasian Women with BRCA1/2 Mutations. Presented at the San Antonio Breast Cancer Symposium.

Asian race and breast cancer subtypes: a study from the California Cancer Registry
Telli, M. L., Kurian, A. W., & Chang, E. (2008). Asian race and breast cancer subtypes: a study from the California Cancer Registry. Journal of Clinical Oncology, 26(15_suppl), 6618.

Percent of Breast Cancers Positive for HER2 Varies By Ethnicity and Social Determinants of Health in California-Implications of Patient Demographics on Laboratory Benchmarks
Carneal, E., Lichtensztajn, D., Clarke, C., Gomez, S., Jensen, K., Kurian, A. W., & Allison, K. (2015). Percent of Breast Cancers Positive for HER2 Varies By Ethnicity and Social Determinants of Health in California-Implications of Patient Demographics on Laboratory Benchmarks. LABORATORY INVESTIGATION, 95, 37A.

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer
Jagsi, R., Griffith, K., & Kurian, A. W. (2015). Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. Journal of Clinical Oncology, 33, 1584.

Technical evaluation of multigene testing for hereditary breast and ovarian cancer
Lincoln, S. E., Kurian, A. W., & Desmond, A. (2015). Technical evaluation of multigene testing for hereditary breast and ovarian cancer. Presented at the San Antonio Breast Cancer Symposium.

The patient experience in a prospective trial of multiplex gene panel testing for cancer risk
Kurian, A. W., Idos, G., & McDonnell, K. (2016). The patient experience in a prospective trial of multiplex gene panel testing for cancer risk. Presented at the San Antonio Breast Cancer Symposium.

Interim analysis of multiplex gene panel testing for inherited susceptibility to breast cancer
Idos, G., Kurian, A. W., & McDonnell, K. J. (2016). Interim analysis of multiplex gene panel testing for inherited susceptibility to breast cancer. Presented at the San Antonio Breast Cancer Symposium.

Prevalence and predictors of second opinions from medical oncologists for early-stage breast cancer: Results from the iCanCare study.
Kurian, A. W., Friese, C. R., & Bondarenko, I. V. (2016). Prevalence and predictors of second opinions from medical oncologists for early-stage breast cancer: Results from the iCanCare study. Presented at the American Society of Clinical Oncology Annual Meeting.

Recurrence risk perception and quality of life after treatment of breast cancer
Hawley, S., Janz, N., Jagsi, R., Griffith, K., Friese, C., & Kurian, A. W. (2016). Recurrence risk perception and quality of life after treatment of breast cancer. Presented at the American Society of Clinical Oncology Annual Meeting.

Breast oncology precision medicine: Genomic testing and treatment at the population level.
Friese, C., Li, Y., Kurian, A. W., & Katz, S. J. (2016). Breast oncology precision medicine: Genomic testing and treatment at the population level. Presented at the American Society of Clinical Oncology Annual Meeting.

Optimizing the Threshold for Genetic Testing for Colorectal Cancer Syndromes
Naghi, L., Spector, K., Haisman, J., & Kurian, A. W. (2016). Optimizing the Threshold for Genetic Testing for Colorectal Cancer Syndromes. Gastroenterology, 150, S160.

Epidemiology and survival patterns of triple negative breast cancer patients with or without BRCA germline mutation in Chinese
Kwong, A., Chau, W. W., Law, F. B. F., Chu, T. W. A., Chan, T. L., & Kurian, A. W. (2013). Epidemiology and survival patterns of triple negative breast cancer patients with or without BRCA germline mutation in Chinese. Presented at the Breakthrough Breast Cancer-TNBC Conference.

Determinants of Patient Choice of Health Care Providers for Breast Cancer Treatment
Rai, A., Thompson, C., Kurian, A. W., & Luft, H. S. (2016). Determinants of Patient Choice of Health Care Providers for Breast Cancer Treatment. Journal of Patient-Centered Research and Reviews, 3(3), 174–75.

Clinical validity and actionability of multigene tests for hereditary cancers in a large multi-center study
Lincoln, S., Kurian, A. W., & Desmond, A. (2016). Clinical validity and actionability of multigene tests for hereditary cancers in a large multi-center study. HUMAN GENOMICS, 10.

Evaluation of a cancer gene sequencing panel in a hereditary risk assessment clinic.
Kurian, A. W., Hare, E. E., & Mills, M. A. (2013). Evaluation of a cancer gene sequencing panel in a hereditary risk assessment clinic. Presented at the ASCO Breast Cancer Symposium.

Lymphopenia after adjuvant radiotherapy to predict poor survival in triple-negative breast cancer
Afghahi, A., Mathur, M., Seto, T., Desai, M., Kenkare, P., Horst, K., … Kurian, A. W. (2015). Lymphopenia after adjuvant radiotherapy to predict poor survival in triple-negative breast cancer. Presented at the American Society of Clinical Oncology Annual Meeting.

Statin use and all-cancer mortality: Prospective results from the Women’s Health Initiative.
Wang, A., Aragaki, A., Tang, J., & Kurian, A. W. (2015). Statin use and all-cancer mortality: Prospective results from the Women’s Health Initiative. Presented at the American Society of Clinical Oncology Annual Meeting.

Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment.
Ellisen, L., Kurian, A. W., & Desmond, A. J. (2015). Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment. Presented at the American Society of Clinical Oncology Annual Meeting.

Prevalence and consequences of second opinions from medical oncologists for early-stage breast cancer: Results from the iCanCare study.
Kurian, A. W., Friese, C. R., & Bondarenko, I. V. (2015). Prevalence and consequences of second opinions from medical oncologists for early-stage breast cancer: Results from the iCanCare study. Presented at the American Society of Clinical Oncology Annual Meeting.

Addressing lack of US insurance coverage of Cancer Hereditary Multiplex Testing
Trosman, J., Weldon, C., Kurian, A. W., & Douglas, M. (2015). Addressing lack of US insurance coverage of Cancer Hereditary Multiplex Testing. Presented at the American Society of Clinical Oncology Annual Meeting.

Multiple-gene panel testing for hereditary cancer risk reveals a racial/ethnic disparity in genetic information
Caswell-Jin, J., Hall, E., Mills, M., Kingham, K., Koff, R., Chun, N., … Kurian, A. W. (2017). Multiple-gene panel testing for hereditary cancer risk reveals a racial/ethnic disparity in genetic information. CANCER RESEARCH, 77.

Genetic counseling, germline genetic testing, and impact of results in patients with newly diagnosed breast cancer
Katz, S. J., Morrow, M., Jagsi, R., & Kurian, A. W. (2017). Genetic counseling, germline genetic testing, and impact of results in patients with newly diagnosed breast cancer. Presented at the San Antonio Breast Cancer Symposium.

Value of cancer care for metastatic breast cancer patients and providers
May, S., Chung, A. H., Vania, D. K., Hou, N., MacEwan, J., Batt, K., & Kurian, A. W. (2017). Value of cancer care for metastatic breast cancer patients and providers. Presented at the San Antonio Breast Cancer Symposium.

Gaps in integrating genetic testing into management of breast cancer.
Katz, S. J., Hawley, S., Jagsi, R., & Kurian, A. W. (2017). Gaps in integrating genetic testing into management of breast cancer. Presented at the American Society of Clinical Oncology Annual Meeting.

Clinical actionability of multi-gene panel tests for hereditary breast and ovarian cancer
Ellisen, L., Lincoln, S., & Kurian, A. W. (2015). Clinical actionability of multi-gene panel tests for hereditary breast and ovarian cancer. Presented at the Montreal Hereditary Breast Ovarian Cancer Meeting.

Yield of multiplex panel testing compared to expert opinion and validated prediction models.
Idos, G., Kurian, A. W., & Ricker, C. (2016). Yield of multiplex panel testing compared to expert opinion and validated prediction models. Presented at the American Society of Clinical Oncology Annual Meeting.

Can precision medicine help achieve the goal of reducing care when the risks exceed the benefits?
Phillips, K. A., Marshall, D. A., & Kurian, A. W. (2019). Can precision medicine help achieve the goal of reducing care when the risks exceed the benefits? Personalized Medicine.

Relationship between rising bilateral mastectomy rates and increased use of neoadjuvant chemotherapy in California, 1998-2012.
Wapnir, I. L., Kurian, A. W., & Lichtensztajn, D. Y. (2016). Relationship between rising bilateral mastectomy rates and increased use of neoadjuvant chemotherapy in California, 1998-2012. Presented at the American Society of Clinical Oncology Annual Meeting.

Dissemination of 21-gene assay testing among female breast cancer patients in the US.
Cronin, K., Petkov, V., Howlader, N., Howe, W., Schussler, N., Kurian, A. W., & Penberthy, L. (2016). Dissemination of 21-gene assay testing among female breast cancer patients in the US. Presented at the American Society of Clinical Oncology Annual Meeting.

Higher peripheral lymphocyte count to predict survival in triple-negative breast cancer
Afghahi, A., Rigdon, J., Purington, N., Desai, M., Pierson, E., Mathur, M., … Kurian, A. W. (2016). Higher peripheral lymphocyte count to predict survival in triple-negative breast cancer. Presented at the American Society of Clinical Oncology Annual Meeting.

Clinical use of the 21-gene assay and patient experiences in early-stage breast cancer.
Katz, S., Friese, C., Li, Y., Deapen, D., Hamilton, A., Ward, K., & Kurian, A. W. (2016). Clinical use of the 21-gene assay and patient experiences in early-stage breast cancer. Presented at the American Society of Clinical Oncology Annual Meeting.

Magnitude of invasive breast cancer risk associated with mutations detected by multiple-gene germline sequencing in 95,561 women.
Hall, M., Hughes, E., Handorf, E., Gutin, A., Allen, B., Hartman, A.-R., & Kurian, A. W. (2016). Magnitude of invasive breast cancer risk associated with mutations detected by multiple-gene germline sequencing in 95,561 women. Presented at the American Society of Clinical Oncology Annual Meeting.

Compliance with guidelines and factors associated with ordering the 21-gene breast cancer assay.
Petkov, V., Howlader, N., Cronin, K., Kurian, A. W., & Penberthy, L. (2016). Compliance with guidelines and factors associated with ordering the 21-gene breast cancer assay. Presented at the American Society of Clinical Oncology Annual Meeting.

Association of ovarian cancer risk with mutations detected by multiple-gene germline sequencing in 95,561 women.
Kurian, A. W., Hughes, E., & Handorf, E. (2016). Association of ovarian cancer risk with mutations detected by multiple-gene germline sequencing in 95,561 women. Presented at the American Society of Clinical Oncology Annual Meeting.

Expanded yield of multiplex panel testing in fully accrued prospective trial.
Idos, G., Kurian, A. W., & Ricker, C. (2017). Expanded yield of multiplex panel testing in fully accrued prospective trial. Presented at the American Society of Clinical Oncology Annual Meeting.

Recent time trends in chemotherapy use and oncologists' chemotherapy recommendations for early-stage, hormone receptor-positive breast cancer.
Kurian, A. W., Bondarenko, I., & Jagsi, R. (2017). Recent time trends in chemotherapy use and oncologists' chemotherapy recommendations for early-stage, hormone receptor-positive breast cancer. Presented at the American Society of Clinical Oncology Annual Meeting.

Breast cancer specific survival in young women <40 years with node-negative luminal breast cancer treated based on tumor gene expression
Shak, S., Roberts, M., Miller, D., Kurian, A. W., Petkov, V., & Penberthy, L. (2017). Breast cancer specific survival in young women <40 years with node-negative luminal breast cancer treated based on tumor gene expression. Annals of Oncology, 28(suppl_5).

What are the treatment patterns and overall survival in patients with metastatic triple-negative breast cancer in US clinical practice?
Bajaj, P., Latremouille-Viau, D., Guerin, A., Reyes, C., Stein, A., Kurian, A. W., & Cortazar, P. (2017). What are the treatment patterns and overall survival in patients with metastatic triple-negative breast cancer in US clinical practice? Annals of Oncology.

Molecular receptor profiles in male mutation carriers with breast cancer
Wapnir, I. L., Kingham, K. E., Mills, M., Ford, J. M., & Kurian, A. W. (2018). Molecular receptor profiles in male mutation carriers with breast cancer. ANNALS OF SURGICAL ONCOLOGY, 24, 112–13.

Outcomes in patients with metastatic triple-negative breast cancer treated in second line in the US real-world setting
Luhn, P., O'Hear, C., Ton, T. G., Hsieh, A., Yi, J., Chang, C. W., … Kurian, A. W. (2018). Outcomes in patients with metastatic triple-negative breast cancer treated in second line in the US real-world setting. Presented at the San Antonio Breast Cancer Symposium.

Comparative effectiveness of nab-paclitaxel versus paclitaxel monotherapy as first-line treatment of metastatic triple-negative breast cancer in US clinical practice
Luhn, P., Chui, S., Hsieh, A., Yi, J., Mecke, A., Bajaj, P., … Kurian, A. W. (2018). Comparative effectiveness of nab-paclitaxel versus paclitaxel monotherapy as first-line treatment of metastatic triple-negative breast cancer in US clinical practice. Annals of Oncology, 29, 101.

Clinical and pathological features of breast cancer among men and women with ATM and CDH1 mutations
Tsang, A., Kingham, K., & Kurian, A. W. (2019). Clinical and pathological features of breast cancer among men and women with ATM and CDH1 mutations. ANNALS OF SURGICAL ONCOLOGY, 26, 69–70.

Modeling reductions in absolute cancer mortality from diagnosing cancers before metastasis, 2006-2015
Clarke, C. A., Hubbell, E., Hartman, A.-R., Colditz, G., Kurian, A. W., & Gomez, S. L. (2019). Modeling reductions in absolute cancer mortality from diagnosing cancers before metastasis, 2006-2015. Value in Health, 22, S296–S297.

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
Caswell-Jin, J. L., Zimmer, A. D., Stedden, W., Kingham, K. E., Zhou, A. Y., & Kurian, A. W. (2019). Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 111(1), 95–98.

Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy
Wu, J., Cao, G., Sun, X., Lee, J., Rubin, D. L., Napel, S., … Li, R. (2018). Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy. RADIOLOGY, 288(1), 26–35.

Natural Language Processing Approaches to Detect the Timeline of Metastatic Recurrence of Breast Cancer.
Banerjee, I., Bozkurt, S., Caswell-Jin, J. L., Kurian, A. W., & Rubin, D. L. (2019). Natural Language Processing Approaches to Detect the Timeline of Metastatic Recurrence of Breast Cancer. JCO Clinical Cancer Informatics, 3, 1–12.

Preventive surgery after multiplex genetic panel testing (MGPT)
Idos, G., Kurian, A. W., Ricker, C., Sturgeon, D., Culver, J., Kingham, K., … Gruber, S. B. (2019). Preventive surgery after multiplex genetic panel testing (MGPT). JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Radiomics features to identify distinct subtypes of triple-negative breast cancers.
Itakura, H., Ikeda, D. M., Okamoto, S., Chen, S.-T., Rister, B., Gude, D., … Kurian, A. W. (2019). Radiomics features to identify distinct subtypes of triple-negative breast cancers. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women's Health Initiative.
Kurian, A. W., Hughes, E., Bernhisel, R., Larson, K., Caswell-Jin, J. L., Shadyab, A. H., … Stefanick, M. L. (2019). Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women's Health Initiative. JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort.
Kurian, A. W., Ward, K. C., Abrahamse, P., Hamilton, A. S., Deapen, D., Morrow, M., & Katz, S. J. (2019). Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort. JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Differences among Asian/Asian American, and Caucasian breast and gynecologic cancer patient reported survivorship needs, symptoms, and illness mindsets (N=220).
Schapira, L., Hofmeister, E., Kurian, A. W., Zion, S., Shen, H., Torres, T., … Palesh, O. (2019). Differences among Asian/Asian American, and Caucasian breast and gynecologic cancer patient reported survivorship needs, symptoms, and illness mindsets (N=220). JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Use, attitudes, and perceptions of tumor genomic testing: Survey of TAPUR physicians.
Bruinooge, S. S., Dueck, A. C., Gray, S. W., Butler, N. L., White, C. B., Smith, M. L., … Schilsky, R. L. (2019). Use, attitudes, and perceptions of tumor genomic testing: Survey of TAPUR physicians. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Oncotype DX DCIS use and clinical utility: A SEER population-based study.
Yuan, Y., Van Dyke, A. L., Kurian, A. W., Negoita, S., & Petkov, V. I. (2019). Oncotype DX DCIS use and clinical utility: A SEER population-based study. JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Decision Making About Genetic Testing Among Women With a Personal and Family History of Breast Cancer.
Scott, D., Friedman, S., Telli, M. L., & Kurian, A. W. (2019). Decision Making About Genetic Testing Among Women With a Personal and Family History of Breast Cancer. Journal of Oncology Practice, JOP1900221.

Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry.
Yang, Y., Shu, X., Shu, X.-O. O., Bolla, M. K., Kweon, S.-S. S., Cai, Q., … Long, J. (2019). Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. EBioMedicine.

Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study.
Gonzales, F. A., Sangaramoorthy, M., Dwyer, L. A., Shariff-Marco, S., Allen, A. M., Kurian, A. W., … Gomez, S. L. (2019). Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study. Journal of Cancer Survivorship : Research and Practice.

Re: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative Response
Caswell-Jin, J. L., & Kurian, A. W. (2019). Re: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative Response. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 111(8), 874.

Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015.
Kurian, A. W., Canchola, A. J., Ma, C. S., Clarke, C. A., & Gomez, S. L. (2019). Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015. Cancer.

Reply to Residual confounding threatens the validity of observational studies on breast cancer local therapy.
Kurian, A. W., Canchola, A. J., & Gomez, S. L. (2020). Reply to Residual confounding threatens the validity of observational studies on breast cancer local therapy. Cancer.

Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer.
Kurian, A. W., Ward, K. C., Abrahamse, P., Hamilton, A. S., Deapen, D., Morrow, M., … Katz, S. J. (2020). Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer. JAMA Oncology, e196400.

Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data.
Ling, A. Y., Kurian, A. W., Caswell-Jin, J. L., Sledge, G. W., Shah, N. H., & Tamang, S. R. (2019). Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data. JAMIA Open, 2(4), 528–37.

Health Disparities in Germline Genetic Testing for Cancer Susceptibility
Parikh, D. A., Dickerson, J. C., & Kurian, A. W. (2020). Health Disparities in Germline Genetic Testing for Cancer Susceptibility. Current Breast Cancer Reports.

Is Breast Cancer in Asian and Asian American Women a Different Disease?
Gomez, S. L., Yao, S., Kushi, L. H., & Kurian, A. W. (2019). Is Breast Cancer in Asian and Asian American Women a Different Disease? JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 111(12), 1243–44.

Abstract P5-03-02: Cancer risks associated with pathogenic variants in the ataxia telangiectasia mutated (ATM) gen
Hall, M., Larson, K., Bernhisel, R., Hughes, E., Rosenthal, E., Singh, N., … Kurian, A. W. (2020). Abstract P5-03-02: Cancer risks associated with pathogenic variants in the ataxia telangiectasia mutated (ATM) gen. Cancer Research.

Abstract P6-08-07: Polygenic breast cancer risk modification in carriers of high and intermediate risk gene mutations
Gallagher, S., Hughes, E., Wagner, S., Tshiaba, P., Rosenthal, E., Roa, B. B., … Robson, M. (2020). Abstract P6-08-07: Polygenic breast cancer risk modification in carriers of high and intermediate risk gene mutations. Cancer Research.

Abstract P3-07-01: Breast cancer-specific mortality (BCSM) in patients age 50 years or younger with node-positive (N+) breast cancer (BC) treated based on the 21-gene assay in clinical practice
Petkov, V., Kurian, A. W., Jakubowski, D. M., & Shak, S. (2020). Abstract P3-07-01: Breast cancer-specific mortality (BCSM) in patients age 50 years or younger with node-positive (N+) breast cancer (BC) treated based on the 21-gene assay in clinical practice. Cancer Research, 80(4).

Abstract P6-08-02: 21-gene recurrence score results according to germline pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 and Lynch Syndrome genes
Kurian, A. W., Abrahamse, P., Ward, K., Hamilton, A. S., Deapen, D., & Katz, S. J. (2020). Abstract P6-08-02: 21-gene recurrence score results according to germline pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 and Lynch Syndrome genes. Cancer Research, 80(4).

Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.
Kurian, A. W., & Katz, S. J. (2020). Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2000140.

Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.
Shu, X., Long, J., Cai, Q., Kweon, S.-S. S., Choi, J.-Y. Y., Kubo, M., … Zheng, W. (2020). Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants. Nature Communications, 11(1), 1217.

Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer.
Kurian, A. W., Bernhisel, R., Larson, K., Caswell-Jin, J. L., Shadyab, A. H., Ochs-Balcom, H., & Stefanick, M. L. (2020). Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer. JAMA, 323(10), 995–97.

Projected Reductions in Absolute Cancer-Related Deaths from Diagnosing Cancers Before Metastasis, 2006-2015.
Clarke, C. A., Hubbell, E., Kurian, A. W., Colditz, G. A., Hartman, A.-R. R., & Gomez, S. L. (2020). Projected Reductions in Absolute Cancer-Related Deaths from Diagnosing Cancers Before Metastasis, 2006-2015. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Daly, M. B., Pilarski, R., Yurgelun, M. B., Berry, M. P., Buys, S. S., Dickson, P., … Darlow, S. D. (2020). NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. Journal of the National Comprehensive Cancer Network : JNCCN, 18(4), 380–91.

A case of a trans-masculine patient receiving testosterone with a history of estrogen receptor-positive breast cancer.
Eckhert, E., Laniakea, B., & Kurian, A. W. (2020). A case of a trans-masculine patient receiving testosterone with a history of estrogen receptor-positive breast cancer. The Breast Journal.

Adherence to breast cancer treatment guidelines according to pathogenic variants in cancer susceptibility genes in a population-based cohort.
Katz, S. J., Morrow, M., & Kurian, A. W. (2019). Adherence to breast cancer treatment guidelines according to pathogenic variants in cancer susceptibility genes in a population-based cohort. JOURNAL OF CLINICAL ONCOLOGY, 37(27).

Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer.
Jayasekera, J., Sparano, J. A., Gray, R., Isaacs, C., Kurian, A., O'Neill, S., … Mandelblatt, J. (2019). Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer. JNCI Cancer Spectrum, 3(4), pkz062.

Combined associations of a polygenic risk score and classical risk factors with breast cancer risk.
Kapoor, P. M., Mavaddat, N., Choudhury, P. P., Wilcox, A. N., Lindström, S., Behrens, S., … Chang-Claude, J. (2020). Combined associations of a polygenic risk score and classical risk factors with breast cancer risk. Journal of the National Cancer Institute.

Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.
Trosman, J. R., Douglas, M. P., Liang, S.-Y. Y., Weldon, C. B., Kurian, A. W., Kelley, R. K., & Phillips, K. A. (2020). Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019. Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 23(5), 551–558.

Abstract IA50: Genetic testing, treatment and mortality after diagnosis of breast cancer or ovarian cancer: The SEER-GeneLINK Initiative
Kurian, A. W. (2020). Abstract IA50: Genetic testing, treatment and mortality after diagnosis of breast cancer or ovarian cancer: The SEER-GeneLINK Initiative. Cancer Epidemiology Biomarkers and Prevention, 29(6).

Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium.
Shariff-Marco, S., Ellis, L., Yang, J., Koo, J., John, E. M., Keegan, T. H., … Kurian, A. W. (2020). Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium. JCO Oncology Practice, 16(6), e517–e528.

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Liu, J., Prager-van der Smissen, W. J., Collée, J. M., Bolla, M. K., Wang, Q., Michailidou, K., … Hollestelle, A. (2020). Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports, 10(1), 9688.

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.
Gallagher, S., Hughes, E., Wagner, S., Tshiaba, P., Rosenthal, E., Roa, B. B., … Robson, M. (2020). Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes. JAMA Network Open, 3(7), e208501.

Genetic testing and results in population-based breast cancer patients and ovarian cancer patients
Kurian, A. W., Ward, K. C., Howlader, N., Deapen, D., Hamilton, A. S., Mariotto, A., … Penberthy, L. (2018). Genetic testing and results in population-based breast cancer patients and ovarian cancer patients. JOURNAL OF CLINICAL ONCOLOGY, 36(15).

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Silvestri, V., Leslie, G., Barnes, D. R., Agnarsson, B. A., Aittomäki, K., Alducci, E., … Ottini, L. (2020). Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). JAMA Oncology.

Promoting colorectal cancer (CRC) screening after multiplex genetic testing and genetic counseling
Idos, G., Kurian, A. W., Ricker, C., Sturgeon, D., Culver, J., Kingham, K., … Gruber, S. B. (2018). Promoting colorectal cancer (CRC) screening after multiplex genetic testing and genetic counseling. JOURNAL OF CLINICAL ONCOLOGY, 36(15).

Promoting breast cancer screening after multiplex genetic panel testing (MGPT) and genetic counseling
Idos, G., Kurian, A. W., Ricker, C., Sturgeon, D., Culver, J., Kingham, K., … Gruber, S. B. (2018). Promoting breast cancer screening after multiplex genetic panel testing (MGPT) and genetic counseling. JOURNAL OF CLINICAL ONCOLOGY, 36(15).

DO RESEARCH PARTICIPANTS DIFFER BY RECRUITMENT SOURCE?OBSERVATIONS FROM A STUDY OF NEWLY-DIAGNOSED BREAST CANCER PATIENTS
Agrawal, A., Benedict, C., Nouriani, B., Medina, J., Kurian, A. W., & Spiegel, D. (2020). DO RESEARCH PARTICIPANTS DIFFER BY RECRUITMENT SOURCE?OBSERVATIONS FROM A STUDY OF NEWLY-DIAGNOSED BREAST CANCER PATIENTS. ANNALS OF BEHAVIORAL MEDICINE, 54, S75.

Pathogenic Variants in Breast Cancer Susceptibility Genes in Older Women-Reply.
Kurian, A. W., Bernhisel, R., & Stefanick, M. L. (2020). Pathogenic Variants in Breast Cancer Susceptibility Genes in Older Women-Reply. JAMA, 324(4), 397–98.

European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.
Ho, W.-K. K., Tan, M.-M. M., Mavaddat, N., Tai, M.-C. C., Mariapun, S., Li, J., … Antoniou, A. C. (2020). European polygenic risk score for prediction of breast cancer shows similar performance in Asian women. Nature Communications, 11(1), 3833.

Abstract 2033: Reducing cancer caregiver burden: A user-centered design approach for an mHealth app
Oakley-Girvan, I., Divi, V., Palesh, O., Daniels, J., Goldman Rosas, L., O'Brien, D., … Longmire, M. R. (2020). Abstract 2033: Reducing cancer caregiver burden: A user-centered design approach for an mHealth app. CANCER RESEARCH, 80.

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk.
Hughes, E., Tshiaba, P., Gallagher, S., Wagner, S., Judkins, T., Roa, B., … Robson, M. (2020). Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk. JCO Precision Oncology, 4.

Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer.
Lincoln, S. E., Nussbaum, R. L., Kurian, A. W., Nielsen, S. M., Das, K., Michalski, S., … Esplin, E. D. (2020). Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer. JAMA Network Open, 3(10), e2019452.

Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants.
Scott, D., Kingham, K., Hodan, R., Ma, C., Mills, M., Ford, J. M., … Telli, M. L. (2020). Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants. JOURNAL OF CLINICAL ONCOLOGY, 38(15).

Performance of the IBIS/Tyrer-Cuzick (TC) Model by race/ethnicity in the Women's Health Initiative.
Kurian, A. W., Hughes, E., Bernhisel, R., Probst, B., Lanchbury, J., Wagner, S., … Stefanick, M. L. (2020). Performance of the IBIS/Tyrer-Cuzick (TC) Model by race/ethnicity in the Women's Health Initiative. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Development and validation of natural language processing (NLP) algorithm for detection of distant versus local breast cancer recurrence and metastatic site.
Karimi, Y., Blayney, D. W., Kurian, A. W., Rubin, D., & Banerjee, I. (2020). Development and validation of natural language processing (NLP) algorithm for detection of distant versus local breast cancer recurrence and metastatic site. JOURNAL OF CLINICAL ONCOLOGY, 38(15).

Comprehensive breast cancer (BC) risk assessment for CHEK2 carriers incorporating a polygenic risk score (PRS) and the Tyrer-Cuzick (TC) model.
Gallagher, S., Hughes, E., Kurian, A. W., Domchek, S. M., Garber, J. E., Probst, B., … Robson, M. E. (2020). Comprehensive breast cancer (BC) risk assessment for CHEK2 carriers incorporating a polygenic risk score (PRS) and the Tyrer-Cuzick (TC) model. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Linking insurance claims across time to characterize treatment, monitoring, and end-of-life care in metastatic breast cancer.
Caswell-Jin, J. L., Callahan, A., Purington, N., Han, S. S., Itakura, H., Sledge, G. W., … Kurian, A. W. (2020). Linking insurance claims across time to characterize treatment, monitoring, and end-of-life care in metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Patterns of social media use and associations with psychosocial outcomes among breast and gynecologic cancer survivors.
Tolby, L. T., Hofmeister, E. N., Fisher, S., Chao, S., Benedict, C., Kurian, A. W., … Palesh, O. G. (2020). Patterns of social media use and associations with psychosocial outcomes among breast and gynecologic cancer survivors. Journal of Cancer Survivorship : Research and Practice.

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
Kramer, I., Hooning, M. J., Mavaddat, N., Hauptmann, M., Keeman, R., Steyerberg, E. W., … Schmidt, M. K. (2020). Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. AMERICAN JOURNAL OF HUMAN GENETICS, 107(5), 837–48.

Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort.
MacInnis, R. J., Knight, J. A., Chung, W. K., Milne, R. L., Whittemore, A. S., Buchsbaum, R., … Terry, M. B. (2020). Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort. Journal of the National Cancer Institute.

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Culver, J. O., Ricker, C. N., Bonner, J., Kidd, J., Sturgeon, D., Hodan, R., … Idos, G. E. (2020). Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer.

Racial/ethnic disparities in survival after breast cancer diagnosis by estrogen and progesterone receptor status: A pooled analysis.
John, E. M., McGuire, V., Kurian, A. W., Koo, J., Shariff-Marco, S., Gomez, S. L., … Wu, A. H. (2020). Racial/ethnic disparities in survival after breast cancer diagnosis by estrogen and progesterone receptor status: A pooled analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer.
Hodan, R., Kingham, K., Cotter, K., Folkins, A. K., Kurian, A. W., Ford, J. M., & Longacre, T. (2020). Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer. Cancer Medicine.

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., … Dwyer, M. A. (2021). Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 19(1), 77–102.

Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes.
Kurian, A. W., Ward, K. C., Abrahamse, P., Hamilton, A. S., & Katz, S. J. (2021). Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes. JNCI Cancer Spectrum, 5(1), pkaa083.

A Population-Based Study of Genes Previously Implicated in Breast Cancer.
Hu, C., Hart, S. N., Gnanaolivu, R., Huang, H., Lee, K. Y., Na, J., … Couch, F. J. (2021). A Population-Based Study of Genes Previously Implicated in Breast Cancer. The New England Journal of Medicine.

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
Johnson, N., Maguire, S., Morra, A., Kapoor, P. M., Tomczyk, K., Jones, M. E., … Fletcher, O. (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer.

Germline pathogenic variants in the Ataxia Telangiectasia Mutated (ATM) gene are associated with high and moderate risks for multiple cancers.
Hall, M. J., Bernhisel, R., Hughes, E., Larson, K., Rosenthal, E. T., Singh, N. A., … Kurian, A. W. (2021). Germline pathogenic variants in the Ataxia Telangiectasia Mutated (ATM) gene are associated with high and moderate risks for multiple cancers. Cancer Prevention Research (Philadelphia, Pa.).

Trends in germline genetic testing and results into survivorship for women diagnosed with breast cancer or ovarian cancer, 2013 to 2017.
Katz, S. J., Morrow, M., & Kurian, A. W. (2020). Trends in germline genetic testing and results into survivorship for women diagnosed with breast cancer or ovarian cancer, 2013 to 2017. JOURNAL OF CLINICAL ONCOLOGY, 38(29).

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019.
Kurian, A. W., Ward, K. C., Abrahamse, P., Bondarenko, I., Hamilton, A. S., Deapen, D., … Katz, S. J. (2021). Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2002785.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Coignard, J., Lush, M., Beesley, J., O'Mara, T. A., Dennis, J., Tyrer, J. P., … Antoniou, A. C. (2021). A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications, 12(1), 1078.

Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.
Choi, Y.-H. H., Terry, M. B., Daly, M. B., MacInnis, R. J., Hopper, J. L., Colonna, S., … Briollais, L. (2021). Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants. JAMA Oncology.

Benchmark Method for Cost Computations Across Health Care Systems: Cost of Care per Patient per Day in Breast Cancer Care.
Blayney, D. W., Seto, T., Hoang, N., Lindquist, C., & Kurian, A. W. (2021). Benchmark Method for Cost Computations Across Health Care Systems: Cost of Care per Patient per Day in Breast Cancer Care. JCO Oncology Practice, OP2000462.

Real-world outcomes of patients with metastatic breast cancer (BC) treated with osteoclast inhibitors (OIs).
Karimi, Y., Purington, N., Liu, M., Kurian, A. W., Sledge, G. W., & Blayney, D. W. (2020). Real-world outcomes of patients with metastatic breast cancer (BC) treated with osteoclast inhibitors (OIs). JOURNAL OF CLINICAL ONCOLOGY, 38(15).

Tobacco Smoking and Risk of Second Primary Lung Cancer.
Aredo, J. V., Luo, S. J., Gardner, R. M., Sanyal, N., Choi, E., Hickey, T. P., … Han, S. S. (2021). Tobacco Smoking and Risk of Second Primary Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.

Impact of COVID-19 on breast cancer care at a Bay Area academic center
Wu, J., Bobo, S., Henry, S., Mills, M., Kurian, A., & Dirbas, F. (2021). Impact of COVID-19 on breast cancer care at a Bay Area academic center. CANCER RESEARCH, 81(4).

Triple-negative breast cancer (TNBC) risk with pathogenic variants (PV) in hereditary cancer predisposition genes
Hall, M. J., Rosenthal, E., San Roman, S., Bernhisel, R., Kidd, J., Hughes, E., … Kurian, A. (2021). Triple-negative breast cancer (TNBC) risk with pathogenic variants (PV) in hereditary cancer predisposition genes. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.

Development of a breast cancer risk assessment model for ATM mutation carriers incorporating tyrer-cuzick and a polygenic risk score (PRS)
Gallagher, S., Hughes, E., Rosenthal, E., Kurian, A. W., Domchek, S., Garber, J., … Robson, M. E. (2021). Development of a breast cancer risk assessment model for ATM mutation carriers incorporating tyrer-cuzick and a polygenic risk score (PRS). CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.

Trends in genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2013-2017
Kurian, A. W., Morrow, M., & Katz, S. (2021). Trends in genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2013-2017. CANCER RESEARCH, 81(4).

Incident comorbidities in a diverse cohort of women treated for early-stage, hormone receptor-positive breast cancer
Gupta, T., Purington, N., Liu, M., Han, S., Sledge, G., Schapira, L., & Kurian, A. (2021). Incident comorbidities in a diverse cohort of women treated for early-stage, hormone receptor-positive breast cancer. CANCER RESEARCH, 81(4).

Limited English Proficiency and Disparities in Health Care Engagement Among Patients With Breast Cancer.
Roy, M., Purington, N., Liu, M., Blayney, D. W., Kurian, A. W., & Schapira, L. (2021). Limited English Proficiency and Disparities in Health Care Engagement Among Patients With Breast Cancer. JCO Oncology Practice, OP2001093.

Development and Use of Natural Language Processing for Identification of Distant Cancer Recurrence and Sites of Distant Recurrence Using Unstructured Electronic Health Record Data.
Karimi, Y. H., Blayney, D. W., Kurian, A. W., Shen, J., Yamashita, R., Rubin, D., & Banerjee, I. (2021). Development and Use of Natural Language Processing for Identification of Distant Cancer Recurrence and Sites of Distant Recurrence Using Unstructured Electronic Health Record Data. JCO Clinical Cancer Informatics, 5, 469–78.

Weakly supervised temporal model for prediction of breast cancer distant recurrence.
Sanyal, J., Tariq, A., Kurian, A. W., Rubin, D., & Banerjee, I. (2021). Weakly supervised temporal model for prediction of breast cancer distant recurrence. Scientific Reports, 11(1), 9461.

Mutations and the Importance of Genetic Testing
Kurian, A. W. (2019). Mutations and the Importance of Genetic Testing. ONCOLOGY-NEW YORK, 33(10), 406–409.

DISPARITIES AND DISCRIMINATION IN BREAST CANCER CARE AND QUALITY OF LIFE
Gonzales, F., Shariff-Marco, S., Dwyer, L., Nuru-Jeter, A., Langer, M., Reeve, B., … Lin-Gomez, S. (2016). DISPARITIES AND DISCRIMINATION IN BREAST CANCER CARE AND QUALITY OF LIFE. ANNALS OF BEHAVIORAL MEDICINE, 50, S52.

Guidelines Do Not Proscribe Surgeons Performing Genetic Testing Reply
Katz, S. J., Morrow, M., & Kurian, A. W. (2019). Guidelines Do Not Proscribe Surgeons Performing Genetic Testing Reply. JAMA SURGERY, 154(3), 269–270.

Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer Reply
Kurian, A. W., & Katz, S. J. (2018). Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer Reply. JAMA ONCOLOGY, 4(12), 1788.

Can We Use Survival Data from Cancer Registries to Learn about Disease Recurrence? The Case of Breast Cancer
Mariotto, A. B., Zou, Z., Zhang, F., Howlader, N., Kurian, A. W., & Etzioni, R. (2018). Can We Use Survival Data from Cancer Registries to Learn about Disease Recurrence? The Case of Breast Cancer. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 27(11), 1332–1341.

Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer.
Jagsi, R., Ward, K. C., Abrahamse, P., Wallner, L. P., Kurian, A. W., Hamilton, A. S., … Hawley, S. T. (2018). Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 36(15).

Gaps in integrating genetic testing into management of breast cancer.
Katz, S. J., Hawley, S. T., Jagsi, R., & Kurian, A. W. (2017). Gaps in integrating genetic testing into management of breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 35(8).

Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients
Rafat, M., Aguilera, T. A., Vilalta, M., Bronsart, L. L., Soto, L. A., von Eyben, R., … Graves, E. E. (2018). Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients. CANCER RESEARCH, 78(15), 4241–4252.

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Kurian, A. W., Ward, K. C., Hamilton, A. S., Deapen, D. M., Abrahamse, P., Bondarenko, I., … Katz, S. J. (2018). Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer. JAMA ONCOLOGY, 4(8), 1066–1072.

Treatment decisions and employment of breast cancer patients: Results of a population-based survey.
Jagsi, R., Abrahamse, P., Lee, K., Wallner, L. P., Janz, N. K., Hamilton, A. S., … Katz, S. J. (2017). Treatment decisions and employment of breast cancer patients: Results of a population-based survey. JOURNAL OF CLINICAL ONCOLOGY, 35.

Factors associated with 21-gene assay receipt among women with lymph node positive breast cancer.
Roberts, M., Kurian, A. W., & Petkov, V. I. (2017). Factors associated with 21-gene assay receipt among women with lymph node positive breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 35.

Recent time trends in chemotherapy use and oncologists' chemotherapy recommendations for early-stage, hormone receptor-positive breast cancer.
Kurian, A. W., Bondarenko, I., Jagsi, R., McLeod, C., Hawley, S. T., Hamilton, A. S., … Katz, S. J. (2017). Recent time trends in chemotherapy use and oncologists' chemotherapy recommendations for early-stage, hormone receptor-positive breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 35.

Dissemination of 21-gene assay testing among female breast cancer patients in the US
Cronin, K., Petkov, V. I., Howlader, N., Howe, W., Schussler, N. C., Kurian, A. W., & Penberthy, L. (2016). Dissemination of 21-gene assay testing among female breast cancer patients in the US. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

Compliance with guidelines and factors associated with ordering the 21-gene breast cancer assay
Petkov, V. I., Howlader, N., Cronin, K., Kurian, A. W., & Penberthy, L. (2016). Compliance with guidelines and factors associated with ordering the 21-gene breast cancer assay. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

Clinical use of the 21-gene assay and patient experiences in early-stage breast cancer
Katz, S. J., Friese, C. R., Deapen, Y. L. D., Hamilton, A. S., Ward, K. C., & Kurian, A. W. (2016). Clinical use of the 21-gene assay and patient experiences in early-stage breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

Association of ovarian cancer (OC) risk with mutations detected by multiple-gene germline sequencing in 95,561 women.
Kurian, A. W., Hughes, E., Handorf, E., Gutin, A., Allen, B., Hartman, A.-R., & Hall, M. J. (2016). Association of ovarian cancer (OC) risk with mutations detected by multiple-gene germline sequencing in 95,561 women. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

Magnitude of invasive breast cancer (BC) risk associated with mutations detected by multiple-gene germline sequencing in 95,561 women.
Hall, M. J., Hughes, E., Handorf, E., Gutin, A., Allen, B., Hartman, A.-R., & Kurian, A. W. (2016). Magnitude of invasive breast cancer (BC) risk associated with mutations detected by multiple-gene germline sequencing in 95,561 women. JOURNAL OF CLINICAL ONCOLOGY, 34(15).

A Time to Decide: Patient Perspectives on Breast Cancer Treatment Decision Making
May, S., Rendle, K., Ventre, N., Frosch, D., & Kurian, A. (2011). A Time to Decide: Patient Perspectives on Breast Cancer Treatment Decision Making. INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 10(4), 456.

Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: More Trouble With Phenocopies Reply
Kurian, A. W., & Whittemore, A. S. (2012). Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: More Trouble With Phenocopies Reply. JOURNAL OF CLINICAL ONCOLOGY, 30(10), 1143–1144.

Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report
Horton, C., LaDuca, H., Blanco, K., Lo, M.-T., Speare, V., Dolinsky, J., & Kurian, A. (2021). Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report. MOLECULAR GENETICS AND METABOLISM. ACADEMIC PRESS INC ELSEVIER SCIENCE.

Financing of germline testing: implications for availability and access
Lin, G., Scheuner, M., Trosman, J., Sales, P., Ackerman, S., Douglas, M., … Phillips, K. (2021). Financing of germline testing: implications for availability and access. MOLECULAR GENETICS AND METABOLISM, 132, S330–S331.

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
Hughes, E., Tshiaba, P., Wagner, S., Judkins, T., Rosenthal, E., Roa, B., … Robson, M. E. (2021). Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing. JCO Precision Oncology, 5.

Treatment and Monitoring Variability in US Metastatic Breast Cancer Care.
Caswell-Jin, J. L., Callahan, A., Purington, N., Han, S. S., Itakura, H., John, E. M., … Kurian, A. W. (2021). Treatment and Monitoring Variability in US Metastatic Breast Cancer Care. JCO Clinical Cancer Informatics, 5, 600–614.

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.
Domchek, S. M., Yao, S., Chen, F., Hu, C., Hart, S. N., Goldgar, D. E., … Palmer, J. R. (2021). Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States. JAMA Oncology.

Receipt of guideline-concordant care among young adult women with breast cancer.
White, D. P., Kurian, A. W., Stevens, J. L., Liu, B., Brest, A. E., & Petkov, V. I. (2021). Receipt of guideline-concordant care among young adult women with breast cancer. Cancer.

EXAMINING ASSOCIATIONS AMONG SEXUAL HEALTH, UNMET CARE NEEDS RELATED TO SEXUALITY, AND DISTRESS IN BREAST AND GYNECOLOGIC CANCER SURVIVORS
Benedict, C., Fisher, S., Kuma, D., Pollom, E., Schapira, L., Kurian, A., … Palesh, O. (2021). EXAMINING ASSOCIATIONS AMONG SEXUAL HEALTH, UNMET CARE NEEDS RELATED TO SEXUALITY, AND DISTRESS IN BREAST AND GYNECOLOGIC CANCER SURVIVORS. ANNALS OF BEHAVIORAL MEDICINE. OXFORD UNIV PRESS INC.

ILLNESS MINDSETS, DEMOGRAPHIC AND MEDICAL FACTORS, AND HEALTH-RELATED QUALITY OF LIFE IN BREAST & GYNECOLOGIC CANCER SURVIVORS
Zeidman, A., Benedict, C., Tolby, L., Zion, S. R., Fisher, S., Kurian, A. W., … Palesh, O. (2021). ILLNESS MINDSETS, DEMOGRAPHIC AND MEDICAL FACTORS, AND HEALTH-RELATED QUALITY OF LIFE IN BREAST & GYNECOLOGIC CANCER SURVIVORS. ANNALS OF BEHAVIORAL MEDICINE. OXFORD UNIV PRESS INC.

Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis.
Su, C. C., Wu, J. T., Neal, J. W., Popat, R. A., Kurian, A. W., Backhus, L. M., … Han, S. S. (2021). Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
Baxter, J. S., Johnson, N., Tomczyk, K., Gillespie, A., Maguire, S., Brough, R., … Fletcher, O. (2021). Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. American Journal of Human Genetics.

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model
Gallagher, S., Hughes, E., Kurian, A. W., Domchek, S. M., Garber, J., Probst, B., … Robson, M. (2021). Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model. JCO Precision Oncology, 5.

Greater Financial Toxicity Relates to Greater Distress and Worse Quality of Life Among Breast and Gynecologic Cancer Survivors.
Benedict, C., Fisher, S., Schapira, L., Chao, S., Sackeyfio, S., Sullivan, T., … Palesh, O. (2021). Greater Financial Toxicity Relates to Greater Distress and Worse Quality of Life Among Breast and Gynecologic Cancer Survivors. Psycho-Oncology.

Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
Kurian, A. W., Hughes, E., Simmons, T., Bernhisel, R., Probst, B., Meek, S., … Stefanick, M. L. (2021). Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative. Cancer.

Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.
Lin, G. A., Trosman, J. R., Douglas, M. P., Weldon, C. B., Scheuner, M. T., Kurian, A., & Phillips, K. A. (2021). Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings. Journal of Genetic Counseling.

Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions.
Jayasekera, J., Sparano, J. A., O'Neill, S., Chandler, Y., Isaacs, C., Kurian, A. W., … Mandelblatt, J. (2021). Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2100651.

Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
Alagoz, O., Lowry, K. P., Kurian, A. W., Mandelblatt, J. S., Ergun, M. A., Huang, H., … Stout, N. K. (2021). Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. Journal of the National Cancer Institute.

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk.
Idos, G. E., Kurian, A. W., Ricker, C., Sturgeon, D., Culver, J. O., Kingham, K. E., … Gruber, S. B. (2019). Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. JCO Precision Oncology, 3.

Mendelian randomisation study of smoking exposure in relation to breast cancer risk.
Park, H. A., Neumeyer, S., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., … Chang-Claude, J. (2021). Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer.

Genetic insights into biological mechanisms governing human ovarian ageing.
Ruth, K. S., Day, F. R., Hussain, J., Martínez-Marchal, A., Aiken, C. E., Azad, A., … Perry, J. R. (2021). Genetic insights into biological mechanisms governing human ovarian ageing. Nature.

Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer.
Kurian, A. W., Abrahamse, P., Bondarenko, I., Hamilton, A. S., Deapen, D., Gomez, S. L., … Ward, K. C. (2021). Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer. Journal of the National Cancer Institute.

Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study.
Oakley-Girvan, I., Davis, S. W., Kurian, A., Rosas, L. G., Daniels, J., Palesh, O. G., … Divi, V. (2021). Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. JMIR Formative Research, 5(8), e22608.

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Morra, A., Escala-Garcia, M., Beesley, J., Keeman, R., Canisius, S., Ahearn, T. U., … Schmidt, M. K. (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research : BCR, 23(1), 86.

Widening cancer care disparities in the adoption of telemedicine during COVID 19: who is left behind?
Liang, S.-Y., Richardson, M., Chen, T., Colocci, N., Kurian, A., de Briun, M., … Chan, J. (2021). Widening cancer care disparities in the adoption of telemedicine during COVID 19: who is left behind? GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE.

The Impact of COVID-19 on Patients With Cancer: A National Study of Patient Experiences.
Rodriguez, G. M., Ferguson, J. M., Kurian, A., Bondy, M., & Patel, M. I. (2021). The Impact of COVID-19 on Patients With Cancer: A National Study of Patient Experiences. American Journal of Clinical Oncology.

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Escala-Garcia, M., Canisius, S., Keeman, R., Beesley, J., Anton-Culver, H., Arndt, V., … Schmidt, M. K. (2021). Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis. Scientific Reports, 11(1), 19787.

Reply to Ritzwoller et al.
Karimi, Y. H., Kurian, A. W., Blayney, D. W., & Banerjee, I. (2021). Reply to Ritzwoller et al. JCO Clinical Cancer Informatics, 5, 1026–1027.

Multiple imputation with missing data indicators.
Beesley, L. J., Bondarenko, I., Elliot, M. R., Kurian, A. W., Katz, S. J., & Taylor, J. M. (2021). Multiple imputation with missing data indicators. Statistical Methods in Medical Research, 9622802211047346.

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.
Yadav, S., Hu, C., Nathanson, K. L., Weitzel, J. N., Goldgar, D. E., Kraft, P., … Couch, F. J. (2021). Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2100640.

Multicancer hereditary syndrome testing: Genetic counselors' perspectives
Weldon, C. B., Liang, S.-Y., Phillips, K. A., Douglas, M. P., Scheuner, M. T., Kurian, A. W., … Trosman, J. R. (2021). Multicancer hereditary syndrome testing: Genetic counselors' perspectives. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Racial/ethnic differences in cancer diagnosed after metastasis: absolute burden and deaths potentially avoidable through earlier detection.
Clarke, C. A., Patel, A. V., Kurian, A. W., Hubbell, E., & Gomez, S. L. (2021). Racial/ethnic differences in cancer diagnosed after metastasis: absolute burden and deaths potentially avoidable through earlier detection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

Twenty-one-gene recurrence score (RS) in germline (g)CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study.
Afghahi, A., Marsh, S., Winchester, A., Gao, D., Parris, H., Axell, L., … Tung, N. M. (2021). Twenty-one-gene recurrence score (RS) in germline (g)CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the United States: Estimates from collaborative simulation modeling.
Alagoz, O., Lowry, K. P., Kurian, A. W., Mandelblatt, J. S., Ergun, M. A., Huang, H., … Stout, N. K. (2021). Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the United States: Estimates from collaborative simulation modeling. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Cancer-specific mortality associated with germline genetic testing results among women with breast cancer or ovarian cancer treated with chemotherapy.
Kurian, A. W., Abrahamse, P., Hamilton, A. S., Deapen, D., Gomez, S. L., Morrow, M., … Ward, K. C. (2021). Cancer-specific mortality associated with germline genetic testing results among women with breast cancer or ovarian cancer treated with chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.
Lowry, K. P., Geuzinge, H. A., Stout, N. K., Alagoz, O., Hampton, J. M., Kerlikowske, K., … Robson, M. E. (2021). Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

A simulation model-based clinical decision tool to guide personalized treatment based on individual characteristics: Does 21-gene recurrence score assay testing change decisions?
Jayasekera, J., Sparano, J. A., Chandler, Y., Isaacs, C., Kurian, A. W., Kushi, L. H., … Mandelblatt, J. S. (2021). A simulation model-based clinical decision tool to guide personalized treatment based on individual characteristics: Does 21-gene recurrence score assay testing change decisions? JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Polygenic risk scores for prediction of breast cancer risk in Asian populations.
Ho, W.-K. K., Tai, M.-C. C., Dennis, J., Shu, X., Li, J., Ho, P. J., … Teo, S.-H. H. (2021). Polygenic risk scores for prediction of breast cancer risk in Asian populations. Genetics in Medicine : Official Journal of the American College of Medical Genetics.

Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics.
Chandler, Y., Schechter, C., Jayasekera, J., Isaacs, C., Kurian, A. W., Cadham, C., & Mandelblatt, J. (2021). Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics. Cancer Medicine.

Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk.
Kehm, R. D., MacInnis, R. J., John, E. M., Liao, Y., Kurian, A. W., Genkinger, J. M., … Terry, M. B. (2021). Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk. JNCI Cancer Spectrum, 5(6), pkab090.

Genetic Insights Into Biological Mechanisms Governing Human Ovarian Ageing
Ruth, K. S., Day, F. R., & Hussain, J. (2021). Genetic Insights Into Biological Mechanisms Governing Human Ovarian Ageing. OBSTETRICAL & GYNECOLOGICAL SURVEY, 76(11), 678–679.

Weight is more informative than body mass index for predicting post-menopausal breast cancer risk: Prospective Family Study Cohort (ProF-SC).
Ye, Z., Li, S., Dite, G. S., Nguyen, T. L., MacInnis, R. J., Andrulis, I. L., … Hopper, J. L. (2021). Weight is more informative than body mass index for predicting post-menopausal breast cancer risk: Prospective Family Study Cohort (ProF-SC). Cancer Prevention Research (Philadelphia, Pa.).

Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes.
Kurian, A. W., Abrahamse, P., Ward, K. C., Hamilton, A. S., Deapen, D., Berek, J. S., … Katz, S. J. (2021). Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes. JCO Precision Oncology, 5.

Common variants in breast cancer risk loci predispose to distinct tumor subtypes.
Ahearn, T. U., Zhang, H., Michailidou, K., Milne, R. L., Bolla, M. K., Dennis, J., … Chatterjee, N. (2022). Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research : BCR, 24(1), 2.

Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Dareng, E. O., Tyrer, J. P., Barnes, D. R., Jones, M. R., Yang, X., Aben, K. K., … Pharoah, P. D. (2022). Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : EJHG.

Rare germline copy number variants (CNVs) and breast cancer risk.
Dennis, J., Tyrer, J. P., Walker, L. C., Michailidou, K., Dorling, L., Bolla, M. K., … Easton, D. F. (2022). Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology, 5(1), 65.

Pathogenic Variants in Less Familiar Cancer Susceptibility Genes: What Happens After Genetic Testing?
Hall, E. T., Parikh, D., Caswell-Jin, J. L., Gupta, T., Mills, M. A., Kingham, K. E., … Kurian, A. W. (2018). Pathogenic Variants in Less Familiar Cancer Susceptibility Genes: What Happens After Genetic Testing? JCO Precision Oncology, 2, 1–10.

Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.
Kurian, A. W., Hughes, E., Handorf, E. A., Gutin, A., Allen, B., Hartman, A.-R. R., & Hall, M. J. (2017). Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. JCO Precision Oncology, 1, 1–12.

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry, K. P., Geuzinge, H. A., Stout, N. K., Alagoz, O., Hampton, J., Kerlikowske, K., … Robson, M. E. (2022). Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis. JAMA Oncology.

Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016.
Lowry, K. P., Callaway, K. A., Lee, J. M., Zhang, F., Ross-Degnan, D., Wharam, J. F., … Stout, N. K. (2022). Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016. Journal of the National Comprehensive Cancer Network : JNCCN, 20(4), 379–386.e9.

Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci.
Chen, H., Fan, S., Stone, J., Thompson, D. J., Douglas, J., Li, S., … Lindström, S. (2022). Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci. Breast Cancer Research : BCR, 24(1), 27.

Relevance of the MHC region for breast cancer susceptibility in Asians.
Ho, P. J., Khng, A. J., Tan, B. K.-T., Tan, E. Y., Tan, S.-M. M., Tan, V. K., … Li, J. (2022). Relevance of the MHC region for breast cancer susceptibility in Asians. Breast Cancer (Tokyo, Japan).

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.
Horton, C., Blanco, K., Lo, M.-T. T., Speare, V., LaDuca, H., Dolinsky, J. S., & Kurian, A. W. (2022). Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations. JNCI Cancer Spectrum, 6(2).

Association of illness mindsets with health-related quality of life in cancer survivors.
Zeidman, A., Benedict, C., Zion, S. R., Fisher, S., Tolby, L., Kurian, A. W., … Palesh, O. (2022). Association of illness mindsets with health-related quality of life in cancer survivors. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association, 41(6), 389–395.

Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population.
Caswell-Jin, J. L., Shafaee, M. N., Xiao, L., Liu, M., John, E. M., Bondy, M. L., & Kurian, A. W. (2022). Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population. Breast Cancer Research and Treatment.

Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.
Archer, S., Fennell, N., Colvin, E., Laquindanum, R., Mills, M., Dennis, R., … Tischkowitz, M. (2022). Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial. Cancers, 14(11).

Chemotherapy Regimens Received by Women with BRCA1/2 Pathogenic Variants for Early-Stage Breast Cancer Treatment.
Kurian, A. W., Abrahamse, P., Hamilton, A. S., Caswell-Jin, J. L., Gomez, S. L., Hofer, T. J., … Katz, S. J. (2022). Chemotherapy Regimens Received by Women with BRCA1/2 Pathogenic Variants for Early-Stage Breast Cancer Treatment. JNCI Cancer Spectrum.

Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations.
Geczik, A. M., Ferris, J. S., Terry, M. B., Andrulis, I. L., Buys, S. S., Daly, M. B., … Genkinger, J. M. (2022). Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations. Breast Cancer Research and Treatment.

Risk-reducing salpingo-oophorectomy consults and practices during the COVID-19 pandemic
O'Mara, A. E., Benedict, C., Kurian, A. W., Wagner, S. K., & Diver, E. J. (2022). Risk-reducing salpingo-oophorectomy consults and practices during the COVID-19 pandemic. Gynecologic Oncology Reports.

Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.
Weldon, C. B., Trosman, J. R., Liang, S.-Y. Y., Douglas, M. P., Scheuner, M. T., Kurian, A., … Phillips, K. A. (2022). Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes. Journal of Genetic Counseling.

Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors.
Benedict, C., Fisher, S., Kumar, D., Pollom, E., Schapira, L., Kurian, A. W., … Palesh, O. (2022). Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors. Seminars in Oncology Nursing, 151316.

What are the considerations in patient selection and timing of risk-reducing mastectomy?
Pederson, H. J., Kurian, A. W., & Al Hilli, Z. (2022). What are the considerations in patient selection and timing of risk-reducing mastectomy? Cleveland Clinic Journal of Medicine, 89(8), 442–444.

Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Frey, M. K., Ahsan, M. D., Bergeron, H., Lin, J., Li, X., Fowlkes, R. K., … Sharaf, R. N. (2022). Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2200303.

The effect of COVID-19 on telehealth: next steps in a post-pandemic life.
Liang, S.-Y. Y., Richardson, M. T., Wong, D., Chen, T., Colocci, N., Kapp, D. S., … Chan, J. K. (2022). The effect of COVID-19 on telehealth: next steps in a post-pandemic life. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics.

Symptoms and survivorship needs differences between "good sleepers" and "bad sleepers" in survivors of breast and gynecologic cancers.
Palesh, O., Tolby, L. T., Hofmeister, E. N., Fisher, S., Solomon, N. L., Sackeyfio, S., … Schapira, L. (2022). Symptoms and survivorship needs differences between "good sleepers" and "bad sleepers" in survivors of breast and gynecologic cancers. Sleep Medicine, 100, 49–55.

Incident comorbidities after tamoxifen or aromatase inhibitor therapy in a racially and ethnically diverse cohort of women with breast cancer.
Gupta, T., Purington, N., Liu, M., Han, S., Sledge, G., Schapira, L., & Kurian, A. W. (2022). Incident comorbidities after tamoxifen or aromatase inhibitor therapy in a racially and ethnically diverse cohort of women with breast cancer. Breast Cancer Research and Treatment.

Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
Lønning, P. E., Nikolaienko, O., Pan, K., Kurian, A. W., Eikesdal, H. P., Pettinger, M., … Knappskog, S. (2022). Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer. JAMA Oncology.

Reducing the risk of breast cancer.
Pederson, H. J., Al-Hilli, Z., & Kurian, A. W. (2022). Reducing the risk of breast cancer. Cleveland Clinic Journal of Medicine, 89(11), 643–652.

Contributions of screening, early-stage treatment, and metastatic treatment to breast cancer mortality reduction by molecular subtype in US women, 2000-2017.
Caswell-Jin, J. L., Sun, L., Munoz, D., Lu, Y., Li, Y., Huang, H., … Plevritis, S. (2022). Contributions of screening, early-stage treatment, and metastatic treatment to breast cancer mortality reduction by molecular subtype in US women, 2000-2017. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.
Dixon-Suen, S. C., Lewis, S. J., Martin, R. M., English, D. R., Boyle, T., Giles, G. G., … Lynch, B. M. (2022). Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. British Journal of Sports Medicine, 56(20), 1157–1170.

Harnessing artificial intelligence to automate delineation of volumetric breast cancers from magnetic resonance imaging to improve tumor characterization.
Zhou, R., Kozlov, A., Chen, S.-T., Okamoto, S., Ikeda, D. M., DeMartini, W., … Itakura, H. (2022). Harnessing artificial intelligence to automate delineation of volumetric breast cancers from magnetic resonance imaging to improve tumor characterization. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Radiomic features quantifying pixel-level characteristics of breast tumors from magnetic resonance imaging predict risk factors in triple-negative breast cancer.
Mantz, A. B., Zhou, R., Kozlov, A., DeMartini, W., Chen, S.-T., Okamoto, S., … Itakura, H. (2022). Radiomic features quantifying pixel-level characteristics of breast tumors from magnetic resonance imaging predict risk factors in triple-negative breast cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

A case-control study of healthcare disparities in sex and gender minority patients with breast cancer.
Eckhert, E., Lansinger, O., Liu, M., Purington, N., Han, S. S., Schapira, L., … Kurian, A. W. (2022). A case-control study of healthcare disparities in sex and gender minority patients with breast cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.
Hughes, E., Wagner, S., Pruss, D., Bernhisel, R., Probst, B., Abkevich, V., … Lanchbury, J. S. (2022). Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition. JCO Precision Oncology, 6, e2200084.

National claims data analysis of outcomes of hospitalized cancer patients without COVID-19 infection during versus prior to the COVID-19 pandemic.
Caswell-Jin, J. L., Shafaee, M. N., Liu, M., Xiao, L., John, E. M., Bondy, M., & Kurian, A. W. (2022). National claims data analysis of outcomes of hospitalized cancer patients without COVID-19 infection during versus prior to the COVID-19 pandemic. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Association of germline genetic testing results with chemotherapy regimens received by women with early-stage breast cancer.
Kurian, A. W., Abrahamse, P., Caswell Jin, J. L., Hamilton, A. S., Hofer, T., Ward, K. C., & Katz, S. (2022). Association of germline genetic testing results with chemotherapy regimens received by women with early-stage breast cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

A pilot study to increase cascade genetic testing in families with hereditary cancer syndromes.
Katz, S. J., Tocco, R., Hawley, S. T., An, L., Hodan, R., Ward, K. C., & Kurian, A. W. (2022). A pilot study to increase cascade genetic testing in families with hereditary cancer syndromes. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Simulation modeling as a tool to support clinical guidelines and care for breast cancer prevention and early detection in high-risk women.
Jayasekera, J., Lowry, K. P., Yeh, J. M., Schwartz, M. D., Wernli, K. J., Isaacs, C., … Stout, N. K. (2022). Simulation modeling as a tool to support clinical guidelines and care for breast cancer prevention and early detection in high-risk women. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Ancestry-specific risk of triple-negative breast cancer (TNBC) associated with germline pathogenic variants (PV) in hereditary cancer (CA) predisposition genes.
Hall, M. J., Hughes, E., Kucera, M., Kidd, J., Bernhisel, R., Hullinger, B., … Kurian, A. W. (2022). Ancestry-specific risk of triple-negative breast cancer (TNBC) associated with germline pathogenic variants (PV) in hereditary cancer (CA) predisposition genes. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics.
Jia, G., Ping, J., Shu, X., Yang, Y., Cai, Q., Kweon, S.-S. S., … Zheng, W. (2022). Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics. American Journal of Human Genetics.

Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer.
Lonning, P. E., Nikolaienko, O., Pan, K., Kurian, A. W., Eikesdal, H. P. P., Pettinger, M., … Knappskog, S. (2022). Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer.
Jayasekera, J., Zhao, A., Schechter, C., Lowry, K., Yeh, J. M., Schwartz, M. D., … Isaacs, C. (2022). Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2201342.

A pilot study to increase cascade genetic risk education and testing in families with hereditary cancer syndromes.
Katz, S., Hawley, S. T., Tocco, R., & Kurian, A. W. (2022). A pilot study to increase cascade genetic risk education and testing in families with hereditary cancer syndromes. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2.
Yadav, S., Boddicker, N. J., Na, J., Polley, E. C., Hu, C., Hart, S. N., … Couch, F. J. (2023). Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2201239.

Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.
Lopes Cardozo, J. M., Andrulis, I. L., Bojesen, S. E., Dörk, T., Eccles, D. M., Fasching, P. A., … Schmidt, M. K. (2023). Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2201978.

Change in practice of RRSO consults and procedures during the COVID-19 pandemic
O'Mara, A., Kurian, A., Benedict, C., & Diver, E. (2022). Change in practice of RRSO consults and procedures during the COVID-19 pandemic. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE.

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Mueller, S. H., Lai, A. G., Valkovskaya, M., Michailidou, K., Bolla, M. K., Wang, Q., … Kuchenbaecker, K. B. (2023). Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine, 15(1), 7.

Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority Groups.
Eckhert, E., Lansinger, O., Ritter, V., Liu, M., Han, S., Schapira, L., … Kurian, A. W. (2023). Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority Groups. JAMA Oncology.

Changes in breast cancer risk and risk factor profiles among U.S.-born and immigrant Asian American women residing in the San Francisco Bay Area.
John, E. M., Koo, J., Ingles, S. A., Kurian, A. W., & Hines, L. M. (2023). Changes in breast cancer risk and risk factor profiles among U.S.-born and immigrant Asian American women residing in the San Francisco Bay Area. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study.
Katz, S. J., Abrahamse, P., Hodan, R., Kurian, A. W., Rankin, A., Tocco, R. S., … An, L. C. (2023). Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study. JCO Oncology Practice, OP2200677.

Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.
Lindström, S., Wang, L., Feng, H., Majumdar, A., Huo, S., Macdonald, J., … Kraft, P. (2023). Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. Journal of the National Cancer Institute.

Disparity in Breast Cancer Care: Current State of Access to Screening, Genetic Testing, Oncofertility, and Reconstruction.
Crown, A., Fazeli, S., Kurian, A. W., Ochoa, D. A., & Joseph, K.-A. A. (2023). Disparity in Breast Cancer Care: Current State of Access to Screening, Genetic Testing, Oncofertility, and Reconstruction. Journal of the American College of Surgeons.

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer.
Ransohoff, J. D., Ritter, V., Purington, N., Andrade, K., Han, S., Liu, M., … Kurian, A. W. (2023). Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer. Nature Communications, 14(1), 2053.

Clinical implications of conflicting variant interpretations in the cancer genetics clinic.
Zukin, E., Culver, J. O., Liu, Y., Yang, Y., Ricker, C. N., Hodan, R., … Idos, G. E. (2023). Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 100837.

Emotion regulation and choice of bilateral mastectomy for the treatment of unilateral breast cancer.
Zhang, J.-X. X., Kurian, A. W., Jo, B., Nouriani, B., Neri, E., Gross, J. J., & Spiegel, D. (2023). Emotion regulation and choice of bilateral mastectomy for the treatment of unilateral breast cancer. Cancer Medicine.

The association between age at breast cancer diagnosis and prevalence of pathogenic variants.
Daly, M. B., Rosenthal, E., Cummings, S., Bernhisel, R., Kidd, J., Hughes, E., … Kurian, A. W. (2023). The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast Cancer Research and Treatment.

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
Nebgen, D. R., Domchek, S. M., Kotsopoulos, J., de Hullu, J. A., Crosbie, E. J., Paramanandam, V. S., … Hickey, M. (2023). Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. BJOG : an International Journal of Obstetrics and Gynaecology.

Germline Genetic Testing After Cancer Diagnosis.
Kurian, A. W., Abrahamse, P., Furgal, A., Ward, K. C., Hamilton, A. S., Hodan, R., … Katz, S. J. (2023). Germline Genetic Testing After Cancer Diagnosis. JAMA.

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Morra, A., Schreurs, M. A., Andrulis, I. L., Anton-Culver, H., Augustinsson, A., Beckmann, M. W., … Hooning, M. J. (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine.

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.
Levi, H., Carmi, S., Rosset, S., Yerushalmi, R., Zick, A., Yablonski-Peretz, T., … Elkon, R. (2023). Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics.

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Middha, P., Wang, X., Behrens, S., Bolla, M. K., Wang, Q., Dennis, J., … Chang-Claude, J. (2023). A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. Breast Cancer Research : BCR, 25(1), 93.

Recurrent BRCA2 exon 3 deletion in Assyrian families.
Hodan, R., Kingham, K., & Kurian, A. W. (2023). Recurrent BRCA2 exon 3 deletion in Assyrian families. Journal of Medical Genetics.

Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer.
Su, C. C., Wu, J. T., Choi, E., Myall, N. J., Neal, J. W., Kurian, A. W., … Han, S. S. (2023). Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer. JAMA Network Open, 6(9), e2335813.

Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
Heald, B., Pirzadeh-Miller, S., Ellsworth, R. E., Nielsen, S. M., Russell, E. M., Beitsch, P., … Hampel, H. (2023). Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives. Journal of the National Cancer Institute.

Elevated cancer risk among individuals with combinations of cancer-related risk factors: A large claims database analysis.
Cong, Z., Ye, X., & Kurian, A. W. (2023). Elevated cancer risk among individuals with combinations of cancer-related risk factors: A large claims database analysis. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Real-world clinical outcomes in patients (pts) with HR+/HER2-metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)
Tolaney, S. M., Punie, K., Kurian, A. W., Ntalla, I., Verret, W., Sadetsky, N., … Jhaveri, K. L. (2023). Real-world clinical outcomes in patients (pts) with HR+/HER2-metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Examining the potential for lead-time bias by estimating stage-specific proportions of deaths due to diagnosed cancer.
Chang, E. T., Clarke, C. A., Colditz, G. A., Gomez, S. L., Kurian, A. W., & Hubbell, E. A. (2023). Examining the potential for lead-time bias by estimating stage-specific proportions of deaths due to diagnosed cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Germline genetic testing use and results after a cancer diagnosis
Kurian, A. W., Abrahamse, P., Furgal, A. K. C., Ward, K. C., Hamilton, A. S., Hodan, R., … Katz, S. (2023). Germline genetic testing use and results after a cancer diagnosis. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Polygenic risk score calibration and association with breast cancer in diverse ancestries
Kucera, M., Hughes, E., Mabey, B., Hullinger, B., Pederson, H. J., Pal, T., … Olopade, O. I. (2023). Polygenic risk score calibration and association with breast cancer in diverse ancestries. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Genetic testing into survivorship after diagnosis of breast cancer.
Katz, S., Hodan, R., Abrahamse, P., Tocco, R., Hofer, T., Wallner, L. P., & Kurian, A. W. (2023). Genetic testing into survivorship after diagnosis of breast cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly, M. B., Pal, T., Maxwell, K. N., Churpek, J., Kohlmann, W., AlHilli, Z., … Darlow, S. D. (2023). NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. Journal of the National Comprehensive Cancer Network : JNCCN, 21(10), 1000–1010.

POSTER SESSION D: PILOT STUDY OF 'ROADMAP TO PARENTHOOD' DECISION AID AND PLANNING TOOL FOR FAMILY BUILDING AFTER CANCER
Benedict, C., Simon, P., Spiegel, D., Kurian, A. W., Alvero, R., Berek, J. S., … Schapira, L. (2023). POSTER SESSION D: PILOT STUDY OF 'ROADMAP TO PARENTHOOD' DECISION AID AND PLANNING TOOL FOR FAMILY BUILDING AFTER CANCER. ANNALS OF BEHAVIORAL MEDICINE. OXFORD UNIV PRESS INC.

A hybrid modelling approach for abstracting CT imaging indications by integrating natural language processing from radiology reports with structured data from electronic health records.
Khan, A., Wu, J., Choi, E., Graber-Naidich, A., Henry, S., Wakelee, H. A., … Han, S. S. (2023). A hybrid modelling approach for abstracting CT imaging indications by integrating natural language processing from radiology reports with structured data from electronic health records. CANCER PREVENTION RESEARCH. AMER ASSOC CANCER RESEARCH.

Risk factors for second primary lung cancer among breast cancer survivors
Choi, E., Lee, J., Wu, J. T., Wakelee, H. A., Schapira, L., Kurian, A. W., & Han, S. S. (2023). Risk factors for second primary lung cancer among breast cancer survivors. CANCER PREVENTION RESEARCH. AMER ASSOC CANCER RESEARCH.

Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
Sorouri, K., Lynce, F., Feltmate, C. M., Davis, M. R., Muto, M. G., Konstantinopoulos, P. A., … Bychkovsky, B. L. (2023). Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps. JCO Precision Oncology, 7, e2300290.

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
Bedrosian, I., Somerfield, M. R., Achatz, M. I., Boughey, J. C., Curigliano, G., Friedman, S., … Robson, M. E. (2024). Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2302225.

Analysis of Breast Cancer Mortality in the US-1975 to 2019.
Caswell-Jin, J. L., Sun, L. P., Munoz, D., Lu, Y., Li, Y., Huang, H., … Plevritis, S. K. (2024). Analysis of Breast Cancer Mortality in the US-1975 to 2019. JAMA, 331(3), 233–241.

Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths.
Chang, E. T., Clarke, C. A., Colditz, G. A., Kurian, A. W., & Hubbell, E. (2024). Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths. Cancer Causes & Control : CCC.

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A.
Kurian, A. W., Bedrosian, I., Kohlmann, W. K., Somerfield, M. R., & Robson, M. E. (2024). Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A. JCO Oncology Practice, OP2300771.

Management of the Gene-Positive Patient
Kurian, A. W. (2023). Management of the Gene-Positive Patient. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. LIPPINCOTT WILLIAMS & WILKINS.

Personalizing Treatment for Early-Stage Breast Cancer
Kurian, A. W. (2023). Personalizing Treatment for Early-Stage Breast Cancer. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. LIPPINCOTT WILLIAMS & WILKINS.

Incidence of Nonkeratinocyte Skin Cancer After Breast Cancer Radiation Therapy.
Rezaei, S. J., Eid, E., Tang, J. Y., Kurian, A. W., Kwong, B. Y., & Linos, E. (2024). Incidence of Nonkeratinocyte Skin Cancer After Breast Cancer Radiation Therapy. JAMA Network Open, 7(3), e241632.

A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care.
Wojcik, K. M., Kamil, D., Zhang, J., Wilson, O. W., Smith, L., Butera, G., … Jayasekera, J. (2024). A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care. Journal of Cancer Survivorship : Research and Practice.

Tumor-Infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California breast cancer family registry.
Ransohoff, J. D., Miller, I., Koo, J., Joshi, V., Kurian, A. W., Allison, K. H., … Telli, M. L. (2024). Tumor-Infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California breast cancer family registry. JNCI Cancer Spectrum.

Racial disparities in breast cancer risk factors and risk management.
Pederson, H. J., Al-Hilli, Z., & Kurian, A. W. (2024). Racial disparities in breast cancer risk factors and risk management. Maturitas, 184, 107949.

US Breast Cancer Mortality-Reply.
Caswell-Jin, J. L., Kurian, A. W., & Plevritis, S. K. (2024). US Breast Cancer Mortality-Reply. JAMA.

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Trentham-Dietz, A., Chapman, C. H., Jayasekera, J., Lowry, K. P., Heckman-Stoddard, B. M., Hampton, J. M., … Mandelblatt, J. S. (2024). Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force. JAMA.

Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy.
Trosman, J. R., Weldon, C. B., Kurian, A. W., Pasquinelli, M. M., Kircher, S. M., Martin, N., … Phillips, K. A. (2023). Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy. Health Affairs Scholar, 1(1), qxad005.

Emergency department involvement in the diagnosis of cancer among older adults: a SEER-Medicare study.
Thompson, C. A., Sheridan, P., Metwally, E., Peacock Hinton, S., Mullins, M. A., Dillon, E. C., … Lyratzopoulos, G. (2024). Emergency department involvement in the diagnosis of cancer among older adults: a SEER-Medicare study. JNCI Cancer Spectrum.

Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients.
Hodan, R., Picus, M., Stanclift, C., Ormond, K. E., Pichardo, J. M., Kurian, A. W., … Idos, G. E. (2024). Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients. Journal of Community Genetics.

Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.
John, E. M., Koo, J., Phipps, A. I., Longacre, T. A., Kurian, A. W., Ingles, S. A., … Hines, L. M. (2024). Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study. Breast Cancer Research : BCR, 26(1), 88.

Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors.
Mabey, B., Hughes, E., Kucera, M., Simmons, T., Hullinger, B., Pederson, H. J., … Gutin, A. (2024). Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 101128.

Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
Katz, S. J., Abrahamse, P., Furgal, A., Hodan, R., Tocco, R. S., Ward, K. C., … Kurian, A. W. (2024). Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2400122.

The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study.
Wojcik, K. M., Caswell-Jin, J. L., Wilson, O. W., Schechter, C., Kamil, D., Kurian, A. W., & Jayasekera, J. (2024). The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study. BMC Cancer, 24(1), 975.

Automated Extraction of Patient-Centered Outcomes After Breast Cancer Treatment: An Open-Source Large Language Model-Based Toolkit.
Luo, M., Trivedi, S., Kurian, A. W., Ward, K., Keegan, T. H., Rubin, D., & Banerjee, I. (2024). Automated Extraction of Patient-Centered Outcomes After Breast Cancer Treatment: An Open-Source Large Language Model-Based Toolkit. JCO Clinical Cancer Informatics, 8, e2300258.

Real-world cancer care utilization among patients with breast cancer with germline variants of uncertain significance
Kurian, A. W., Hughes, K. S., Young, S. M. N., Russell, E. M., Facio, F., Moretz, C., … Korn, W. M. (2024). Real-world cancer care utilization among patients with breast cancer with germline variants of uncertain significance. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Attitudes and engagement about cascade genetic testing in a population-based cohort of women diagnosed with cancer
Katz, S. J., Ward, K. C., Hamilton, A. S., Abrahamse, P., Hodan, R., Kurian, A. W., … Hawley, S. T. (2024). Attitudes and engagement about cascade genetic testing in a population-based cohort of women diagnosed with cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Use of surgery for de novo metastatic breast cancer (mBC)
Dickerson, J., Tang, H., Thompson, C., Gomez, S. L., Satoyoshi, M., Kurian, A. W., & Caswell-Jin, J. L. (2024). Use of surgery for de novo metastatic breast cancer (mBC). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Improving a polygenic risk score (PRS) for breast cancer (BC) risk assessment in diverse ancestries
Simmons, T., Hughes, E., Pruss, D., Kucera, M., Roa, B., Judkins, T., … Gutin, A. (2024). Improving a polygenic risk score (PRS) for breast cancer (BC) risk assessment in diverse ancestries. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Tamoxifen for breast cancer prevention among survivors of pediatric lymphoma previously treated with chest radiation: Clinical benefits, harms and tradeoffs
Yeh, J. M., Stein, S. K., Stratton, K., Taylor, C. S., Leisenring, W. M., Alagoz, O., … Diller, L. (2024). Tamoxifen for breast cancer prevention among survivors of pediatric lymphoma previously treated with chest radiation: Clinical benefits, harms and tradeoffs. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Timing of genetic testing referral and genetic testing results in patients with multiple primary cancers
Hodan, R., Ritter, V., Han, S. S., Narayan, S., Satoyoshi, M., & Kurian, A. W. (2024). Timing of genetic testing referral and genetic testing results in patients with multiple primary cancers. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Uptake of risk-reduction, surveillance, and therapeutic interventions among patients with breast cancer with pathogenic germline variants
Kurian, A. W., Young, S. M. N., Russell, E. M., Facio, F., Moretz, C., Heald, B., … Tung, N. M. (2024). Uptake of risk-reduction, surveillance, and therapeutic interventions among patients with breast cancer with pathogenic germline variants. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Real-world duration of interruptions in imaging and endocrine therapy (ET) after pregnancy in early-stage estrogen receptor (ER) positive breast cancer (BC)
Lewinsohn, R. M., Dickerson, J., Ransohoff, J. D., Luo, I., Satoyoshi, M., Ritter, V., … Kurian, A. W. (2024). Real-world duration of interruptions in imaging and endocrine therapy (ET) after pregnancy in early-stage estrogen receptor (ER) positive breast cancer (BC). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Association of polygenic-based breast cancer risk prediction with patient management
Taber, K. J., Hughes, E., Gutin, A., DeHart, B., Becker, L., Jasper, J., … Kurian, A. W. (2024). Association of polygenic-based breast cancer risk prediction with patient management. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Non-receipt of targeted and immunotherapies in diverse patients with metastatic cancers
Veenstra, C. M., Abrahamse, P., Kurian, A. W., Hawley, S. T., Farias, A., Hamilton, A. S., … Katz, S. J. (2024). Non-receipt of targeted and immunotherapies in diverse patients with metastatic cancers. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Breast Cancer Screening With Mammography: An Updated Decision Analysis for the U.S. Preventive Services Task Force
Trentham-Dietz, A., Chapman, C. H., Lowry, K. P., Heckman-Stoddard, B., Hampton, J. M., Caswell-Jin, J. L., … Alagoz, O. (2024). Breast Cancer Screening With Mammography: An Updated Decision Analysis for the U.S. Preventive Services Task Force . Agency for Healthcare Research and Quality.

Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk.
McDonald, J. A., Liao, Y., Knight, J. A., John, E. M., Kurian, A. W., Daly, M., … Terry, M. B. (2024). Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk. JAMA Network Open, 7(8), e2427441.

Surgery and Suicide Deaths Among Patients With Cancer.
Chen, M. L., Gomez, S. L., O'Hara, R., John, E. M., Morris, A. M., Kurian, A. W., & Linos, E. (2024). Surgery and Suicide Deaths Among Patients With Cancer. JAMA Network Open, 7(9), e2431414.

Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk.
Kalia, S. S., Boddicker, N. J., Yadav, S., Huang, H., Na, J., Hu, C., … Kraft, P. (2024). Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

Real-world treatment patterns and outcomes in patients with HR+/HER2- metastatic breast cancer treated with chemotherapy in the United States
Tolaney, S. M., Punie, K., Carey, L. A., Kurian, A. W., Ntalla, I., Sjekloca, N., … Jhaveri, K. (2024). Real-world treatment patterns and outcomes in patients with HR+/HER2- metastatic breast cancer treated with chemotherapy in the United States. Esmo Open, 103691.

Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study.
Graber-Naidich, A., Choi, E., Wu, J. T., Ellis-Caleo, T. J., Neal, J., Wakelee, H. A., … Han, S. S. (2024). Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study. Clinical Lung Cancer.

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2.
Phillips, K.-A. A., Kotsopoulos, J., Domchek, S. M., Terry, M. B., Chamberlain, J. A., Bassett, J. K., … Milne, R. L. (2024). Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2400176.